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1Chapter 1:
Introduction and Objectives
1.1 Introduction: Biomaterials
According to Williams [1], a biomaterial is “a substance that has been engineered
to take a form which, alone or as part of a complex system, is used to direct, by control of
interactions with components of living systems, the course of any therapeutic or
diagnostic procedure, in human or veterinary medicine”. In that sense, biomaterials as a
scientific domain is a recent area of knowledge —it is just over half century old—. It is a
multidisciplinary field that encompasses aspects of medicine, biology, chemistry, physics
and materials science. Besides, it also sits on a foundation of engineering principles [2].
Although the methodic study and design of biomaterials is recent, its use dates far
back into ancient civilizations. Artificial eyes, ears, teeth, and noses have been found on
Egyptian mummies [3]. Chinese and Indians used waxes, glues, and tissues in
reconstructing missing or defective parts of the body [4]. The Mayan people fashioned
nacre teeth from seashells in roughly 600 A.D. Similarly, an iron dental implant in a
corpse dated 200 A.D. was found in Europe [2]. The Aztecs commonly used gold and
silver plates to replace pieces of the skull following craniotomies [5]. So on, long lists of
historic examples are mentioned in bibliographic references. Nevertheless, the modern era
of biomaterials started in the late 1800s with two key innovations: the implementation of
aseptic techniques reducing the potential of infection-related complications and the
radiograph techniques for visualization of skeletal structures [6]. This allowed developing
implants design, mainly metallics, more compatible with the human body.
Nowadays, biomaterials are not only used as implants or prostheses, which are
typical functions, but they also have a wide range of medical and non-medical
applications. Table 1 lists some of the most significant ones. This table illustrates the
success reached by biomaterials and its importance to modern medical therapies. In
economic terms, biomaterials are a potential market. They have evolved over the last 50
Chapter 1
2
years or so to a US$100 billion endeavor [7]. At this moment, still many applications will
require synthetics, so, it is possible to predict that the demand for biomaterials will grow
through this century.
Table 1. Some uses for biomaterials (from Ratner and Bryant [7]).
Medical uses Non-medical uses
Artery graft Arrays for DNA and diagnostics
Artificial heart valve Bioremediation materials
Implants (breast, cochlear, dental, etc.) Biosensors
Tubes (feeding, guidance, drainage, etc.) Bioseparations, chromatography
Drug and gene delivery devices Biofouling-resistant materials
Hydrocephalous shunt Biomimetics for new materials
Intraocular lens, keratoprosthesis Cell culture/cell scaffolds
Joints (hip, knee, shoulder, etc.) Controlled release for agriculture
Pacemaker Electrophoresis material
Renal dialyzer Microelectromechanical systems (MEMS)
Stent Muscles (artificial) and actuators
Tissue adhesive Nanofabrication
Urinary catheter Neural computing/biocomputer
1.2 Porous silicon
Porous silicon (PSi) was discovered in 1956 by Uhlir [8] during some experiments
of electropolishing, but was just reported as a technical note. Since then, PSi was ignored
by scientific community until 1990 when its visible luminescence was discovered by
Canham [9].
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PSi is constituted by silicon nanocrystallites immersed in a porous silica skeleton
[10]. This complex porous structure may reach a large internal surface area (500
m
2/cm3) [11]. In Fig 1, a FESEM image and a scheme of PSi are shown. The silicon
nanocrystallite is covered by amorphous, silicon which is oxidized over time [12]. In
TEM image of Fig. 2-a, individual silicon nanocrystallites are identified. They are round
in the range between 20 Å and 80 Å without a preferential orientation (polycrystalline
diffraction pattern) [13].
Figure 1. a) FESEM image of PSi layer (by J. Hernandez-Montelongo), and b) scheme in detail of typical
PSi components (by J. R. Martín-Palma).
This particular nanostructure of PSi generates efficient photoluminescence and
electroluminescence at room temperature in the visible (blue and red) and infrared [9,14].
The most accepted theory indicates that blue band is linked to the presence of surface
silicon dioxide; the red band is due to quantum confinement of silicon nanocrystallite
possibly supplemented by surface states; and the infrared band is correlated with dangling
bonds and bandgap luminescence in large crystallites [10,15]. These properties made PSi
a promising material for optoelectronic applications insomuch that publications dedicated
to PSi grew exponentially in the 90’s [16]. Among the most important PSi applications in
optoelectronics are: light emitting devices (LED’s) [17], solar cells [18], Bragg reflectors
[19], optical waveguides [20] and photodetectors [21].
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Figure 2. a) TEM image of PSi, and b) nanocrystallite size histogram (from Martín-Palma et al. [13]).
1.3 Porous silicon as a biomaterial
In 1995, Canham [22] demonstrated for first time the bioactivity of PSi by means
of the hydroxycarbonate-apatite in-vitro growth on PSi surface over periods of days to
weeks. Since then, other PSi bioapplications have been developed: biosensing [23], drug
delivery [24], tissue engineering [25], tumor imaging [26], bioreactor platform [27], and
others. These PSi scopes have been achieved because PSi is a porous semiconductor and
its large surface area and surface chemistry provide a high reactivity. Hence, it is possible
to generate a specific chemical composition or molecular adsorption on its surface [27].
Besides, PSi is also an excellent biomaterial given its biocompatibility, biodegradability
and bioresorbability [28]. These PSi bioproperties are largely generated due to its
particular susceptibility to oxidation. The silicon oxide is readily dissolved by body fluids
[24] and later non-toxically eliminated as silicic acid in the urine [29]. Besides, PSi has
been also combined with other materials, introduced into its pores or deposited on its
surface, in order to obtain composites [30] which can extend or develop its applications
and properties, including the bio [24,31].
In that sense, PSi research in medical and non-medical applications is still
increasing because it is a suitable biomaterial for commercial industry. Silicon —the
substrate to produce it—, is a low cost commodity compatible with high-tech electronic
industry. Only in the semiconductor industry, the most relevant market for silicon, it has
been predicted an increase from US$125 billion in 1998 to US$ 3.3 trillion in 2020 [32].
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Among the most relevant uses of PSi as a biomaterial are drug delivery and cell
scaffolds. The development of PSi-based devices oriented to these applications is
increasingly relevant [33,34].The state of the art of them is outlined below.
1.3.1 PSi-based drug delivery devices
Drug delivery systems can be defined as materials designed to introduce
therapeutic agents into the body with at least one of the following purposes [35]:
a) Sustain drug action at predetermined rates.
b) Localize drug action by placing a rate controlled system near or at the desired
tissue or organ.
c) Target drug action by using carriers or chemical derivatization to deliver drug
to a particular site.
Within this context, PSi is an attractive biomaterial for drug delivery applications.
The size of the pores and the surface chemistry of the pore walls can be easily changed
and controlled. Depending on the size and the surface chemistry of PSi pores, increased
or sustained release of the loaded drug can be obtained [36]. Nevertheless, surface
modified PSi is more frequently utilized than native PSi for drug delivery due to its
enhanced stability.
Fig. 3 illustrates schematically the use of PSi as drug delivery device: as a single
material and after surface modification; and Table 3 highlights several PSi modification
methods that have been investigated for different drug release applications. Furthermore,
but to a lesser extent, PSi composites —PSi combined with biopolymers—, have been
shown to yield improved control over drug release kinetics and improved stability in
aqueous media. Biopolymers that have been incorporated into PSi for drug delivery
applications include [24]: polylactide, polydimethylsiloxane, polyethylene, polystyrene,
polycaprolactone and poly(N-isopropylacrylamide).
On the other hand, the drug delivery devices based on PSi have been tested in
different organs, such as intestinal epithelial cells [37]; adenocarcinoma cancer cells [38];
kidney, liver, and spleen [39]; tissues of the eye [34,40]; and others.
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Figure 3. PSi-based drug delivery device: a) as a single material,
b) surface modified (from Anglin et al.[24]).
Table 2. Some of the most relevant drug delivery systems using modified PSi (from
Jarvis et al. [33]).
PSi surface modification Result: Tested with
Thermal carbonization Controlled release for highly soluble drugs: ibuprofen
Reduced drug crystallinity: ibuprofen, antypirine, anitidine
Reduction in pH dependent solubility: furosemide
Thermal hydrocarbonization Sustained release: melatonan II, ghrelin antagon, peptide YY3-36
Increased dissolution from smaller pores: ibuprofen
Oxidation at 300 ºC Improved dissolution of poorly soluble drugs: griseofulvin,
urosemide, antypirine, ranitidine
Increased Caco-2 cell layer permeation: griseofulvin
Sustained release: peptide YY3-36
Oxidation at 800 ºC Controlled release, pH triggered release: vancomycin
Improved protein activity: lysozyme
pNIPAM grafting Temperature controlled release: camptothecin
Electrochemical methylation Controlled release, pH triggered release: vancomycin
load
infuse
polymer load
drug
load
surface
modified
drug
stabilizat.
drug
infuse
p l
a)
b)
c)
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1.3.2 PSi-based cell scaffolds
According to Williams [41], tissue engineering “is the persuasion of the body to
heal itself through the delivery to appropriate sites of molecular signals, cells and
supporting structures”. In that sense, a cell scaffold for a tissue engineering application is
a substrate designed to support the appropriate cellular activity, including the facilitation
of molecular and mechanical signaling systems, in order to optimize tissue regeneration,
without eliciting any undesirable local or systemic responses in the eventual host [42].
Due to its biomedical properties, PSi has been incorporated in tissue engineering
as cell scaffold. Its micro/nano-morphology can regulate cell behavior [43]. Its flexible
surface chemistry can be tailored to improve the PSi-cell interaction interfacial properties
[44]. It is a bioactive material in simulated plasma, whereby corrosion of the film with
release of Si(OH)4 stimulates calcification and posterior hydroxyapatite formation [25].
Besides, PSi has an advantage over other biomaterials, its ability to be easily degraded in
aqueous solutions into non-toxic silicic acid [45]. An example of the PSi use as cell
scaffold is shown in Fig. 4.
Figure 4. Neurobastoma cells after 24h growth: a1) confocal image of macrostructured PSi, a2) SEM
image of macrostructured PSi, b1) confocal image of nanostructured PSi and b2) SEM image of
nanostructured PSi (from Khung et al. [46]).
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The confocal microscope and SEM images in Fig. 4 are representative of
neurobastoma cells cultured on two different PSi surfaces: macrostructured (pores: 1000-
3000 nm) and nanostructured (pores: 50-100 nm) [46]. Different growth and cell
morphology in function of PSi pore size is perceived. Therefore, specific stimulations in
cells can be controlled as needed.
As in other PSi applications, the use of PSi as a cell scaffold can take place in the
form of a single material, after appropriate surface modification, or as a composite
biomaterial. Table 4 lists the most highlighted cases of cell cultures on PSi-based cell
scaffolds.
Table 4. Cell cultures on different kinds of PSi scaffolds.
PSi scaffold Cell culture Reference
Nanostructured B50 neuron and Chinese hamster
ovary
Bayliss et al. [47,48]
Oxidized by ozone Hepatocyte Chin et al. [49]
Thermally oxidized, carbon
layer coated, methillized.
Human retinal endothelial, mouse
aortic endothelial, murine melanomas,
neuronal mouse, hamster ovarian
Angelescu et al. [50]
Composited with
polycaprolactone and
calcificated by SBF
Fibroplast Coffer et al. [25]
Whitehead et al. [51]
Different PSi patterns Rat hippocampal neuron Sapelkin et al [52]
Modified by ozone oxidation,
silanizated and coated with
collagen and serum
Rat pheochromocytoma (PC12) and
human lens epithelial
Low et al. [45]
Nano and macrostructured Osteoblast Sun et al. [43]
Macrostructured and
oxidized by H2O2
Osteoblast Sun et al. [44]
Structured with pore size
continuous gradient
Neuroblastoma Khung et al. [46]
Thermally oxidized and
aminosilanized
Human ocular Low et al. [34]
1D nanostructured PSi
micropatterns
Human mesenchymal stem cells Punzón-Quijorna et al.
[53], Muñoz et al. [54]
2D nanostructured PSi
micropatterns
Human mesenchymal stem cells Torres-Costa et al.
[55]
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1.4 Objectives
As already introduced, the use of PSi as a biomaterial is currently increasing; not
only because of its interesting biomedical properties (biocompatibility, biodegradability
and bioresorbability [28]), but also because PSi is potentially marketable due to its
compatibility with high-tech electronic industry. Nevertheless, it is necessary to adapt its
properties depending on the specific envisaged application. In that sense, this thesis aims
at exploring new PSi modifications to obtain new advanced PSi-based structures for
biomaterials applications. The new PSi-based biomaterials proposed in this thesis were
designed to work in the field of drug delivery and cell scaffolds, some of the most
important PSi uses as a biomaterial. The motivations and particular objectives of this
thesis are:
1) To contribute to the PSi utilization in drug delivery applications. PSi-
biopolymer composites are attractive candidates for drug delivery devices because they
can display new chemical and physical characteristics, which are not exhibited by the
individual constituents. In that sense, a section is dedicated to propose a new composite
based on PSi and β-cyclodextrin polymer. The cyclodextrins are cyclic oligosaccharides
that are widely used in pharmaceutical applications. Due to their characteristic cavity and
their ability to form reversible complexes with drugs they have been used as efficient
delivery carriers. Hence, the objective of this section was the development of new PSi/
cyclodextrin composites, their synthesis, characterization and test as potential drug
delivery systems. For this reason, the first part of the title of this volume:
“PSi/Cyclodextrin Drug Delivery Hybrids”. In order to explore a whole set of
experimental conditions, the study involved the use of two kinds of PSi substrates,
nanostructured and macrostructured, two drugs, ciprofloxacin (an antibiotic) and
prednisolone (an anti-inflammatory), released in two media, pure water and phosphate
buffered saline.
2) To provide new formulations of PSi for applications as cell scaffolds. In order
to use PSi as cell scaffold in bone tissue engineering, deposition of calcium phosphate
ceramics in its hydroxyapatite phase is required. This is because hydroxyapatite is an
osteoconductive ceramic and constitutes the main inorganic part of natural bone.
Different techniques to produce calcium phosphate coatings on PSi have been used, but
not all of them are targeted to hydroxyapatite phase or are compatible to integrate
Chapter 1
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biological systems. Within this context, this section concerns a new hydroxyapatite
deposition technique on PSi. Based on cyclic steps, the technique is developed from a sol-
gel method to its optimization by an electrochemical method. Hence, the objective of this
section was the development of new PSi-composite cell scaffolds. This contribution is
thus outlined in second part of the title of this thesis: “PSi/Calcium Phosphate Bioceramic
Cell Scaffolds”. The study is based on a cyclic calcium phosphate deposition technique,
optimizing the hydroxyapatite phase synthesis from spin coating to electrochemical
activation with the purpose of finding an optimized process. The composites were also
characterized and biologically tested.
1.5 Thesis organization
This thesis is organized as follows:
In Chapter 2, the fundamentals of the experimental techniques used in this work
are explained. It starts with the know how behind the electrochemical etching of PSi, both
nanostructured and macrostructured. Afterwards, as the thesis deals with the development
of new PSi-based substrates for two different applications, the principles concerning the
methods used to modify PSi in each case are discussed. On the other hand, the bases of
characterization techniques are briefly explained. Four kinds of microscopy methods and
thirteen different physicochemical characterization techniques have been used. It should
be noted that not all of them were used in each PSi configuration. Finally, the general
concepts of drug release profiles and the in vitro biological assays are explained.
Next, two chapters correspond to each application envisaged: Chapter 3 is focused
on the functionalization of PSi by β-cyclodextrin-citric acid in situ polymerization for
drug delivery applications and Chapter 4 deals with the calcium phosphate deposition on
PSi for cell scaffold applications. Each one of these chapters is structured as a paper: a
brief introduction, method and materials, results and discussions, conclusions and
references.
Finally, Chapter 5 summarizes the conclusions and discusses the perspectives for
these new PSi-based biomaterials.
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Chapter 2:
Fundamentals of Experimental
Techniques
2.1 Introduction
This chapter is divided in two main sections; the first one is related to PSi
formation and the fundamentals used to synthesize the composite materials aimed in this
study. Besides, the experimental conditions (raw materials, stabilization parameters and
protocols) for each synthesis technique are described in detail.
In the second part, the basic principles of the characterization techniques are
briefly explained, as well as the details of the parameters used for every analysis. A
remarkable aspect of this thesis is the wide fan of characterization protocols and methods
used. However, not all of them were used to characterize the two different types of PSi
composites considered in this thesis.
2.2 Synthesis techniques
The composite biomaterials were fabricated using porous silicon (PSi) as a
support matrix. Two kinds of PSi were used: nanostructured (nPSi) and macrostructured
(mPSi). nPSi was used as a substrate in both kind of composites: PSi/cyclodextrin hybrids
and PSi/calcium phosphate bioceramics; but mPSi was only used in the PSi hybrids.
Besides, the experimental procedure for the processing of each type of PSi is detailed.
The basic concepts of the techniques utilized to fabricate the PSi-based composites are
also briefly discussed: β-cyclodextrin-citric acid in situ polymerization and cyclic calcium
phosphate deposition (by means of spin coating and electrochemical activation). The
conditions used in each case are also detailed.
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2.2.1 Electrochemical etching: Porous silicon formation
PSi is formed by an electrochemical etching of Si in a HF-based electrolyte [1]. In
this technique, the Si wafer acts as the anode and Pt electrodes are used as cathode and
counter electrodes. The system is connected to a power supply, which regulates the
current/voltage on the Si crystal [2]. Due to the fact that HF is extremely corrosive;
Teflon beakers are commonly used as reactors. The electrochemical process is mainly
controlled by the current/voltage and solution composition. A scheme of the
electrochemical cell utilized in this thesis is shown in Fig. 1.
Figure 1. Scheme of the electrochemical cell used for PSi formation
(adapted from Advanced Micromachining Tools [3]).
Different models have been proposed to explain pore formation in PSi. However,
the most accepted model concerning the Si dissolution/PSi formation is the series of
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electrochemical reactions schematized in Fig. 2 [4]. Initially, the Si atoms on the surface
are passivated by Si-H bonds (1). Holes are injected from the bulk to the Si surface by the
power supply. Thus, a nucleophillic attack on a Si-H bond by F- anion can occur and a Si-
F bond is formed (2). The Si-F bond causes a polarization effect allowing a second F-
anion to attack and replace the remaining hydrogen bonds. Two hydrogen atoms can then
combine, injecting an electron into the substrate (3). The polarization induced by the Si-F
bonds reduces the electron density of the remaining Si-Si backbonds making them
susceptible to further attack by HF in such a manner that the remaining silicon surface
atoms are bonded to the hydrogen atoms, which will be nucleophillically attacked again
by a F- anion forming silicon tretrafluoride (SiF4) (4). The SiF4 molecule reacts with HF
to form the highly stable SiF62- fluoroanion. The surface returns to its ‘neutral’ state until
another hole is available (5).
Figure 2. Model of Si dissolution (from Arrand [5]).
The Si dissolution depends on the injected holes (h+) in the system. When they
reach the surface, the previously described reaction mechanism is initiated. As the Si/HF
interface shows a Schottky junction behavior (Fig. 3), these holes reach the interface by
crossing the space charge region by thermionic effect [6]. After first pores are formed,
holes begin to accumulate at the bottom reducing the potential barrier, thus enhancing Si
dissolution in that zone. On the other side, the remaining Si structure (PSi formed) is
more resistive because of charge carrier depletion; wherewith in depth pore growth is
favored [7]. By this effect, PSi homogeneous layer and varying porosity multilayer
formation are possible. Nevertheless, if anodic current is high enough, injected charge can
1) 3)2)
4)
5)
-
-
- -
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be higher than F- infiltration into the pore, which produces the dissolution of the PSi
columns (Fig. 4). The limit of the anodic current to produce PSi dissolution is known as
the electropolishing threshold or critical current [8].
Figure 3. Scheme of Si/PSi/HF interface during electrochemical etching. CB = Conduction band,
VB = Valence band, εF = Fermi energy (from Arrand [5] and Torres-Costa [9]).
Figure 4. a) Si dissolution at the bottom of pores, where charge carriers preferentially emerge to the
electrolyte, and b) Si electropolishing; anodic current is high enough so that holes reach the top of the PSi
columns, which induce its dissolution (from Torres-Costa [9]).
PSiSi
CB
VB
h+
εF
HF
electrolyte
HF
electrolyte
Si
H
HF
electrolyte
PSi
Si
h+
Fundamentals of Experimental Techniques
19
All the properties of PSi, such as porosity, thickness, pore diameter and
microstructure, depend on Si wafer properties and anodization conditions [1]. These
conditions include HF concentration, current density, wafer type and resistivity,
anodization duration, illumination (in n-type Si mainly), temperature and drying
conditions. In Table 1 the main effects of anodization parameters on PSi formation are
summarized.
Table 1. Main effects of anodization parameters on PSi formation (from Bisi et al. [1]).
An increase of … yields a Porosity Etching rate Critical current
HF concentration Decreasing Decreasing Decreasing
Current density Increasing Increasing -
Anodization time Increasing Almost constant -
Temperature - - Increasing
Wafer doping (p-type) Decreasing Increasing Increasing
Wafer doping (n-type) Increasing Increasing -
i) Nanoporous silicon
PSi can be classified as a function of its pore size. According to IUPAC guidelines,
the different types of PSi have been categorized as microporous (≤2 nm), mesoporous (2–
50 nm) and macroporous (>50 nm) [10]. Two kinds of PSi were fabricated in this thesis:
mesoporous and macroporous. However, in order to underline the difference between
them, the mesoporous was labeled as nanoporous silicon (nPSi), and the macroporous as
macroporous silicon (mPSi).
nPSi is formed from doped silicon substrates, either n-type or p-type [11].
Normally, pore sizes are in the range of 10-50 nm. Its macroscopic surface is slightly
darker-looking compared to bulk silicon, and of excellent smoothness. The inner surface
area is high and could easily be etched in low-concentration alkaline solutions.
In the case of p-type, lightly doped Si produces a fine network of pores, whereas
heavily doped p-type material produces more columnar structures [12]. Different
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parameters such as current density, electrolyte composition (mainly HF concentration),
crystalline orientation or process temperature also influence the reaction kinetics and
hence the morphology of nPSi [13]. As a result, a wide variety of structures, porosity and
pore morphology may be achieved depending on the fabrication parameters [14]. Some of
the most representative nPSi morphologies and structures are presented in Fig. 5.
Figure 5. Cross-sectional TEM images showing the basic differences in morphology among different types
of nPSi samples from: a) p-type Si, b) p+-type Si, c) n-type Si, and d) n+-type Si
(from Smith and Collins [14]).
ii) Preparation of nanoporous silicon
The nPSi used in this thesis was fabricated in a homemade Teflon electrochemical
cell connected to a potentiostat/galvanostat (HG&G model 263), which is controlled by
the computer program Research Electrochmistry 4.3 [9].
a) b)
c) d)
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nPSi was fabricated by electrochemical etching of 1.5 x 1.5 cm2 p+ type Si (boron-
doped, orientation <100>, resistivity of 0.01-0.02 Ωcm) in a HF:EtOH solution at 1:2
(v/v), HF at 48%. This kind of Si was selected due to its hole availability, which
facilitates pore formation [1]. HF was mixed with ethanol in the electrolyte solution in
order to improve the infiltration of HF molecules into the PSi pores avoiding the
formation of hydrogen bubbles, which may cause an inhomogeneous etching [15]. The
HF-ethanol proportion was selected to achieve columnar pores in p+ type Si, a highly
homogenous structure suitable for the formation of PSi-based composites [16].
In order to find a mechanically stable thin nPSi layer to withstand the composites
formation steps, a range of current densities and reaction times were tested, from 60 to
120 mA/cm2 and from 60 to 200 s, respectively. nPSi formation was carried out under
illumination with a 150 W halogen lamp; the illumination helped to form more electron-
hole pairs in the Si-electrolyte interface, which enhances the Si dissolution resulting in a
more homogeneous porosity [9]. Finally, after nPSi synthesis, the samples were rinsed
with EtOH and dried with nitrogen.
iii) Macroporous silicon
Usually, mPSi is obtained from low-doped n-type Si [11]. The most critical
parameter is the presence of illumination during etching. Regular arrays of pores with
pitch ≥2 m, 1 m wide and more than 100 m deep can be obtained. The resistivity of Si
should be chosen in agreement with the pitch density, otherwise branching or dying of
pores occurs. Also current density should be adjusted according to the desired porosity. In
addition, due to the concentration gradients of the electrolyte in the pores, a linearly
increasing current density has to be used [1].
Formation of mPSi is more difficult from p-type than n-type Si [11], resulting in
relatively short and ‘‘bulgy’’ pores. However, using different kinds of organic
electrolytes its synthesis is facilitated and stabilized so that pore depths can be up to 400
m [17]. Fig. 6 shows examples of different types of p-macropores.
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Figure 6. Cross-sectional SEM images of some mPSi samples obtained from p-type Si with 4 wt. % HF in:
a) acetonitrile on {1 1 1} Si, b) dimethylformamide on {5 1 1} Si, c) dimethylformamide on {1 0 0} Si
(perfect pores) d) acetonitrile + diethyleneglycol (protic additive) on {1 0 0} Si. (from Foll et al. [17])
iv) Preparation of macroporous silicon
As in the case of nPSi, mPSi formation was carried out in a homemade Teflon
electrochemical cell.
mPSi was fabricated by electrochemical etching of 1.5 x 1.5 cm2 p-type Si (boron-
doped, orientation <100>, resistivity of 23-31 Ωcm) in a HF:DMF (dimethylformamide,
C2H6NCOH) solution at 1:6 (v/v), HF at 48% [17]. In this case, the macroporuous
formation is favored because the higher resistivity of Si wafer produces a lower density of
holes at the Si-electrolyte interface, which results in lower surface points of
electrochemical etching. The used solvent, DMF, is an organic aprotic solvent (unable to
form hydrogen bonds) [18].
Samples were fabricated in ranges of current density and reaction time from 5 to
40 mA/cm2 and from 300 to 1800 s, respectively. mPSi synthesis was carried out under
a) b)
c) d)
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illumination with a 150W halogen lamp. After their synthesis, samples were rinsed with
EtOH and dried with nitrogen.
v) Porous silicon stabilization: Oxidation
The nanoscale architecture of PSi is inherently fragile [19] and shows a great
reactivity due to the chemical instability of the surface just after formation. Rapid
modification of the surface occurs if it is not passivated [20]. That is why in some cases
PSi is modified to enhance its mechanical and chemical stabilization. Besides, in order to
provide PSi surfaces with diverse properties, it is also functionalized using various
chemical reactions such as [21]: oxidation, hydrosilylation, cathodization, amino-silation.
One strategy to obtain long-term PSi stability is to oxidize its surface under
controlled conditions [22]. Thermal oxidation is the most commonly used technique for
the passivation of PSi. It consists on the annealing of porous samples at high temperature
in ambient air or under controlled O2 atmosphere for time intervals ranging from a few
tens of minutes to a few hours. In general, temperatures used are within the 300 °C -
1000 °C range. By this process, PSi layers are transformed in SiO2 [20]:
Si + O2 → SiO2 (Eq. 1)
Nevertheless, a 300 ºC stabilizing pretreatment prior to higher temperature
oxidization is necessary to avoid pore coalescence. The oxygen content at the end of the
process varies with substrate, oxidization temperature and duration [1].
Another common stabilization method is chemical oxidation. Depending on the
process, the chemical reactions on PSi surface can produce hydroxyl, silyloxy and alkoxy
terminated bonds [21]. Different inorganic and organic agents have been used in PSi
chemical oxidation, such as hydrogen peroxide, nitric acid or boiling water [1]. In
addition to stabilization, oxidation treatments also introduce hydrophilicity to PSi which
is an essential requirement in biological applications.
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vi) Chemical oxidation: Experimental procedure
This substrate treatment was necessary to enhance the cyclodextrin incorporation
into the porous structure. It is well documented that fresh PSi surface is mainly composed
of Si-H bonds [23,24]. A simple chemical post-treatment of PSi is using H2O2. Its
oxidation process involves different reactions: Si-H bonds can be transformed to Si-OH,
Si-O-Si or -OySi-Hx. The oxidation process is represented in the schematic of Eq. 2
[25,26]:
(Eq. 2)
In the case of PSi/cyclodextrin hybrids, both PSi substrates (nPSi and mPSi) were
chemically oxidized with H2O2 (30% v/v) for 2 h [25], rinsed with EtOH and dried with
nitrogen. For the synthesis of PSi/calcium phosphate bioceramics, the chemical
stabilization was not required.
2.2.2 Preparation of PSi/cyclodextrin hybrids
The processing of PSi/cyclodextrin hybrids was carried out by functionalization of
PSi with modified β-cyclodextrin. A brief review of cyclodextrins and the classes of
cyclodextrin-based polymers is exposed. Later, the particular in-situ procedure of
polymerization carried out on PSi samples is detailed.
i) Cyclodextrins
Cyclodextrins (CDs) and their derivatives have been used as building blocks for
the development of a wide variety of polymeric networks and assemblies [27]. CD-based
polymeric materials, such as hydrogels, nano/microparticles, and micelles, are frequently
studied for pharmaceutical and biomedical applications, for example, sustained release
[28] and targeted delivery of bioactive substances (low molecular weight drugs, peptides,
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proteins, genetic material and others) [29]. Other outstanding but less common
applications relate to tissue engineering [30] and medical diagnostics [31].
CDs are non-toxic cyclic polysaccharides with a hydrophilic outer surface (C-OH
groups) and a hydrophilic apolar cavity (C-O-C and C-H bonds) [32] (Fig. 7-a). They are
built from six to eight (α= 6, β = 7, γ = 8) D-glucose units. The D-glucose units are
covalently linked to carbon atoms C1 and C4 forming a rigid cavity where guest molecules
can be partially or totally enclosed (Fig. 7-b) [33]. Table 2 lists the main characteristics of
CDs.
Figure 7. a1) Chemical structure of β-CD, and a2) its toroidal shape. Models of inclusion complexes
between prostaglandin E2 and: a) α-CD, b) β-CD and c) γ-CD (from Davis and Brewster [32]).
Table 2. CD characteristics (from Loftsson and Brewster [34]).
Characteristic α-CD β-CD γ-CD
Number of D-glucose units 6 7 8
Molecular weight (Da) 972 1135 1459
Central cavity diameter (Å) 4.7-5.3 6.0-6.5 7.5-8.3
Water solubility at 25 ºC (g/L) 145 18.5 232
b1 b2 b3
a1 a2
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Since each guest molecule is individually surrounded by a CD, this can lead to
advantageous changes in its chemical and physical properties [35]:
- Stabilization of light- or oxygen-sensitive substances.
- Modification of the chemical reactivity of guest molecules.
- Fixation of very volatile substances.
- Improvement of solubility of substances.
- Modification of liquid substances to powders by encapsulation.
- Protection against degradation of substances by microorganisms.
- Masking of ill smell and taste.
- Masking pigments or the color of substances.
- Catalytic activity of CDs with guest molecules.
These properties of CDs and their derivatives are also viable to use in applications
of other fields such as analytical chemistry, agriculture, food and toilet articles [36].
ii) Classes of cyclodextrin-based polymers and copolymers
It is possible to classify CD-based polymers in four main classes: crosslinked,
linear tube, pendent and linear polymer (Fig. 8). CD-crosslinked polymers are three-
dimensional crosslinked macromolecular networks formed by polymers and CDs (Fig. 8-
a). The crosslinks can be formed by either covalent bonds or physical cohesion forces
between the polymer segments such as ionic bonds, hydrogen bonds, van der Waals
forces, and hydrophobic interactions [37]. CD-linear tube polymers have a tubular
structure (Fig. 8-b). The cylinders can be formed by using molecules that organize the
CDs into a tubular configuration, such as cholesterol [38]; then, the polymers are formed
from the tubular configurations by crosslinking between the CDs. In the case of CD-
pendent polymers and CD-linear polymers, the first ones contain CDs as pendent moieties
in a polymer backbone (Fig. 8-c), and the second ones have CDs as part of the polymer
backbone (Fig. 8-d) [32].
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Figure 8. Main classes of CD-based polymers: a) crosslinked, b) linear tube,
c) pendent, and d) linear polymer (from Davis and Brewster [32]).
iii) PSi functionalization with β-cyclodextrin-citric acid polymer: Experimental procedure
The PSi/CD hybrids were fabricated by means of the protocol developed at Unité
Matériaux et Transformations (UMET) of Université Lille 1. Firstly, a monomer solution
was prepared with 10 g of β-cyclodextrin (βCD, Roquette, Lestrem France), 3 g of
NaH2PO2·H2O (Aldrich, Saint Quentin Fallavier, France) as catalyst and 10 g of citric
acid (Aldrich, Saint Quentin Fallavier, France) in 100 mL of distilled water. Oxidized
nano and macroporous silicon samples (nPSi-COx and mPSi-COx, respectively) were
immersed in this solution for 15 min with stirring. Afterwards, the excess of monomer
solution on the top surfaces was carefully removed by capillarity using a soft cellulosic
tissue, leaving a thin film on the top. The samples were dried, first at room temperature,
and later at 90 °C for 1 h in each case. The polymerization [39] in PSi samples was
carried out at 140 °C for 25 min thereby obtaining the nPSi-CD and mPSi-CD samples.
Afterwards they were washed with distilled water for 15 min with stirring, rinsed with
EtOH and dried at 90 ºC for 1 h.
The crosslinked polymer obtained (polyCD) by βCD and citric acid is due to a
polyesterification mechanism between hydroxyl groups of βCD and carboxylic groups of
citric acid, which contains three carboxylic groups as detailed in the following equation
(Eq. 3) [39].
a) b)
c) d)
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(Eq. 3)
A global scheme of PSi/CD hybrid synthesis is illustrated in Fig. 9.
Figure 9. Synthesis scheme of porous silicon-cyclodextrin hybrids: 1) synthesis of nano
and micro porous structures, 2) chemical oxidation, 3) cyclodextrin polymerization.
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2.2.3 PSi/calcium phosphate bioceramics synthesis
The PSi/calcium phosphate bioceramics were fabricated by calcium phosphate
coating on nPSi, at room temperature, from independent solutions of calcium and
phosphate by two different deposition methods: cyclic spin coating and cyclic
electrochemical activation. Below, a brief fundamental review of calcium phosphates and
both deposition techniques used (spin coating and electrochemical deposition) are
explained. Besides, the particular experimental procedure of calcium phosphate cyclic
deposition on nPSi by each method is detailed.
i) Calcium phosphates
Calcium phosphates (CaPs) are calcium salts of the tribasic phosphoric acid
(H3PO4), and thus the chemical composition of many CaPs includes H2PO4-, HPO4-2,
and/or as incorporated water. Diverse combinations of oxides of calcium and phosphorus
(both in the presence and absence of water) provide a variety of CaPs, which are
distinguished by the type of the phosphate anion: ortho- (PO4-3), meta- (PO4-), pyro-
(P2O7-4), and poly- ((PO3)n-n) [40]. Some relevant properties of different CaPs are shown
in Table 3.
The importance of CaPs in the field of biomedicine arises from the fact that they
constitute the major mineral component of bones and teeth [41]. Due to their
compositional similarities to bone mineral and to their excellent biocompatibility, they are
the most widely used bone substitutes in bone tissue engineering [42]. Besides, recent
studies have shown that some CaPs also exhibit osteoinductive properties, and not only
osteoconductive [41]. Thus, these materials can induce osteogenic differentiation in vitro
or in vivo and not only act as substrates for bone deposition.
There are different techniques to produce CaP coatings including biomimmetic
growth [43], sol-gel processes [44], plasma spraying [45], sputtering [46], laser ablation
[47] or electrodepostion [48]. In this thesis spin coating (a sol-gel derived process) and
electrochemical deposition techniques were used so that their characteristics are briefly
explained.
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Table 3. Properties of different calcium phosphates (from Bose and Tarafder [42]).
Calcium phosphates Chemical formula Ca/P molar ratio Solubility
Monocalcium phosphate
monohydrate Ca(H2PO4)2·H20 0.5 7.2 x 10
-2
Monocalcium phosphate Ca(H2PO4)2 0.5 7.2 x 10-2
Dicalcium phosphate dihydrate CaHPO4·2H20 1.0 2.5 x 10-7
Dicalcium phosphate CaHPO4 1.0 1.26 x 10-7
Calcium pyrophosphate Ca2O7P2 1.0 -
Octacalcium phosphate Ca8H2(PO4)6·5H20 1.33 2.51 x 10-97
α-Tricalcalcium phosphate α-Ca3(PO4)2 1.5 3.16 x 10-26
-Tricalcalcium phosphate -Ca3(PO4)2 1.5 1.25 x 10-29
Amorphous calcium phosphate Ca3(PO4)2·nH20 1.2-2.2 a
Calcium-deficient hydroxyapatite Ca10-x(HPO4)x(PO4)6-x(OH)2-x (0<x<1) 1.5-1.67
b
Carbonated apatite Ca5(PO4,CO3)3 1.67 -
Hydroxyapatite Ca10(PO4)6(OH)2 1.67 2.35x 10-59
Oxyapatite Ca10(PO4)6O 1.67 -
Tetracalcium phosphate Ca4O(PO4)2 2.0 1 x 10
-38
-
1 x 10-44
aSolubility varies due to its metastable nature
bSolubility varies depending on the stoichiometry
Normally, CaPs can be formed under different pH conditions from slightly acidic
to strongly basic [40], depending on the CaP to synthesize and the technique used. It is
very important to mention this variable because PSi gets dissolved when submerged into
basic solutions [49]. This factor was paramount to consider in PSi/calcium phosphate
bioceramics synthesis.
ii) Spin coating deposition
The typical spin coating deposition involves the application of a solution on a
substrate followed by acceleration of the substrate at a specific rotational speed (Fig. 10).
Alternatively, the solution may be applied while the substrate is spinning. The thickness
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and morphology of the film obtained from a particular material in a given solvent at a
given concentration is highly reproducible. These three properties depend highly on
rotational speed, viscosity, volatility, diffusivity, molecular weight and concentration of
the solutes [50]. There is also a shift dependence on the amount of solution deposited, the
rate of deposition and the spinning time.
Figure 10. Schematic illustration of the spin coating.
iii) Calcium phosphate deposition by cyclic spin coating: Experimental procedure
CaP deposition by cyclic spin coating (CSC) was carried out using independent
calcium (Ca) and phosphate (P) precursor aqueous solutions: 0.1M CaCl2:EtOH at 2:1
(v/v) at pH = 5.5 and 0.1M Na3PO4:EtOH at 2:1 (v/v) adjusted to pH = 7.2 with H3PO4,
respectively. The standard deposition consisted on alternating 100 μL of Ca and the same
quantity of P solution onto a nPSi layer rotated by spin coating at 2500 rpm during 60 s.
This process was repeated for ten cycles in a row (Fig. 11). Additionally, CaP was
synthesized at different ratios of Ca/P solution volumes (VCa/VP = 1, 1.67, 2). Additional
experiments were performed under different pH of P solution (pH = 7.2, 9.7, 12.3). All
reactions were carried out with fresh Ca and P solutions stirred at room temperature.
Air flow
Radial
liquid flow
Radial
liquid flow
Evaporation
Angular velocity
Solution filmSubstrate
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Figure 11. Scheme of CaP deposition on nPSi by CSC.
iv) Electrochemical deposition
The reduction of metal ions M+n in aqueous solution is represented by:+ → (Eq. 4)
This can be accomplished by means of two different processes: an electrodeposition
process in which z electrons (e) are provided by an external power supply, or an
electroless (autocatalytic) deposition process in which a reducing agent in the solution is
the electron source (no external power supply is involved). Both processes,
electrodeposition and electroless deposition, constitute the electrochemical deposition
technique [51]. Fig. 12 shows a cell scheme used for electrochemical deposition and
Table 4 compares the nature of reactions occurring in it.
Ca+2/EtOH HPO4-2/EtOH
(f) = pH, V (f) = pH, V
nPSi
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Figure 12. Cell scheme used for electrochemical deposition.
Table 4. Nature of reactions and their sites occurring in electrodeposition (from Rao and
Trivedi [52]).
Property Electrodeposition Electroless deposition
Driving force External power supply Reducing agent (RA) and autocatalyticproperty of the deposited metal
Cathode reaction Mn+ + ne M Mn+ + RA  M
Anodic reaction M  ne  Mn+ RA  ne (RA)Oxidized form
Overall reaction Manode  Mcathode Mn+ + RA  M + (RA)Oxidized form
Anodic site Anode itself Work piece
Cathodic site Work piece Work piece
v) Calcium phosphate deposition by cyclic electrochemical activation: Experimental
procedure
The CaP deposition on nPSi by cyclic electrochemical activation (CEA) was
performed using the same Ca and P aqueous solutions than in CSC: 0.1M CaCl2:EtOH at
2:1 (v/v) at pH 5.5 and 0.1M Na3PO4:EtOH at 2:1 (v/v) adjusted to pH = 7.2 with H3PO4,
respectively. The electrodeposition of CaP on nPSi was carried out by applying a cathodic
Electrolyte
DC power
supplye e
Cathode
(work piece)Anode
M+nMMM+n
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current to the Ca solution and an anodic current to the P solution under illumination.
Every deposition resulted from the application of 20 Ca/P cycles (30 s each) by means of
a potentiostat/galvanostat (HG&G model 263) (Fig. 13). Experiments were done at three
different Ca/P current density ratios (ICa/IP = 1, 1.67, 2, keeping the P current density
constant at 1 mA/cm2) and at three different Ca/P reaction time ratios (tCa/tP = 1, 1.67, 2,
keeping the P reaction time fixed at 30 s). All reactions were carried out with fresh Ca
and P solutions at room temperature.
Figure 13. Scheme of CaP deposition on nPSi by CEA.
2.3 Characterization techniques
In this section, the basic principle of each technique used to characterize the
biocomposites is briefly explained, as well as their respective utilization parameters. The
characterization techniques are organized in four sub-sections: microscopy,
physicochemical techniques, in vitro cell assays and drug release profiles.
nP nP
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2.3.1 Microscopy
i) Scanning Electron Microscopy (SEM) and Field Emission Electron Microscopy
(FESEM)
A scanning electron microscope uses a collimated and focused beam of high-
energy electrons to produce images from a sample’s surface [9]. The electron beam is
generated by a gun usually located at the top of a high vacuum column (Fig. 14). The
electron beam is accelerated by a potential up to 50 kV, while is collimated and focused
by electromagnetic lenses. When it reaches the sample, the electron beam scans the
sample surface by a series of deflection coils. Two independent detectors collect the
secondary electrons for images with better resolution, and the backscattered electrons for
topographic, compositional or electronic maps.
Figure 14. Schematic design of a scanning electron microscope.
Electron gun
Electron beam
Anode
Backscattered
electron detector Secondary
electron detector
Scanning coil
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The difference between SEM and FESEM is that the FESEM electron gun has a
much smaller emission area than the traditional thermionic guns used in SEM, which
gives rise to brighter sources and a smaller scanning beam diameter [9]. In turn, as the
emission in FESEM is produced by tunnel effect, the energy spread of emitted electrons
is significantly reduced, leading to an induction of chromatic aberration. This allows
reducing the acceleration voltage of analysis, thereby reducing damage to the samples and
charge effects. Thus, images with higher resolution can be obtained.
The microstructure and morphology of PSi and composites were studied by using
a conventional SEM (Hitachi S-3000N) detecting secondary electrons and/or a FESEM
(Philips XL-40FEG), operated at 20 keV and 10 keV, respectively. Both are facilities at
Servicio Interdepartamental de Investigación (SIdI), Universidad Autónoma de Madrid.
ii) Atomic Force Microscopy (AFM)
Images obtained by an atomic force microscope are obtained by detecting the
forces between a sample and a probing tip, which is attached to a cantilever [53]. In
response to the force between sample and tip, the cantilever is deflected. As the samples
are mounted on a piezoelectric base, the images are taken by scanning the sample relative
to the probing tip and registering the deflection of the cantilever and/or the z-movement
of the piezoelectric as a function of “x” and “y” positions (Fig. 15).
Two main operational modes are distinguished in AFM: contact and non-contact
mode. When AFM is operated in non-contact mode, the interaction forces can be resolved
up to distances of 10 to 100 nm, such as Van der Waals, electrostatic, magnetic or
capillary forces [54]. If the cantilever is vibrated at a constant frequency, the AFM is
called tapping mode. In contact mode, the AFM can reach a distance in the order of Å
between the probing tip and sample. In this mode, ionic repulsion forces allow the surface
topography to be traced with high resolution (it is possible to achieve atomic resolutions).
Besides, frictional forces and elastic or plastic deformations can be detected under
appropriate conditions.
Fundamentals of Experimental Techniques
37
Figure 15. AFM scheme with reflective light detection.
This technique was utilized in tapping mode to study the roughness and
topography of PSi substrates, before and after functionalization with polyCD. A NT-
MDT Solver equipped with a Smena head and Si cantilevers (force constant 5 N/m, first
harmonic frequency of 158 KHz) were used. To generate topographic images and to
calculate sample roughness, the NT-MDT SPM Software was used on scanning areas of
4x4 μm2. The equipment was provided by the Institute for Health and Consumer
Protection of the Joint Research Centre in Ispra, Italy.
iii) Immunofluorescence Microscopy
The luminescence principle of fluorophores consists on electronic transitions in a
band structure between molecular levels [54]. In Fig. 16 an electronic energy diagram
corresponding to a fluorophore is represented. It consists on a singlet ground S0, a singlet
excited state S1 and an intermediate triplet T1 of longer lifetime. Light absorption
promotes electron excitation and subsequent emission (fluorescence).
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Figure 16. Schematic representation of an energy diagram (Jablonsky diagram) corresponding to a
fluorophore: Excitation and emission.
Immunofluorescence microscopy is mainly used to evaluate cells in suspension,
cultured cells, tissues, beads and microarrays for the detection of specific proteins [55]. In
most cases the sample of interest is labelled with a fluorescent substance known as a
fluorophore and then illuminated through the lens with an UV source. The illumination
light is absorbed by the fluorophores (now linked to the sample) and causes them to emit
a longer wavelength light. This light is separated from the surrounding radiation with
filters, which allow seeing only the fluorescent wavelength (Fig. 17).
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Figure 17. Scheme of a fluorescence microscope.
An inverted fluorescence microscope (Olympus IX81) coupled to a CCD colour
camera was used to observe human mesenchymal stem cells (hMSCs) used during the
evaluation of the biocompatibility of the PSi/CaP composites. Phalloidin-Alexa 488 and
Dapi were used as fluorophores. This microscope is a facility at Departamento de
Biología Molecular, Universidad Autónoma de Madrid.
2.3.2 Physicochemical techniques
i) Gravimetric analysis
Gravimetry is a quantitative determination of an analyte based on its mass. The
porosity of a solid is defined as the fraction of void within the structure, which can be
easily determined by gravimetric measurements. In the case of PSi, the Si wafer is
weighted before anodization (m1), just after anodization (m2), and after a rapid dissolution
of the whole porous layer in a 3% KOH solution (m3) [1]. Then, porosity is given by the
following equation: (%) = ( )( ) (Eq. 5)
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Emission filter Excitation filter
Dichroic mirror
Objective
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Chapter 2
40
This technique was carried out using an automatic standard micro and analytical
balance of readability of 0.01 mg (RADWAG AS 60/C/2).
ii) Direct galvanostatic method
The direct galvanostatic method is a typical electrochemical technique used for the
study of electrode kinetics in constant current electrodeposition by means of recording the
potential-time characteristic (Fig. 18) [56]. The equipment used for these measurements
was a potentiostat/galvanostat (HG&G model 263).
Figure 18. The input (a) and response (b) in a direct galvanostatic measurement.
iii) Water contact angle
The water contact angle is a technique that measures the wettability of solid
surfaces [57], that is to say, it allows knowing if a solid surface is hydrophilic or
hydrophobic. This is achieved by measuring the intrinsic contact angle (θc) formed by a
water drop on a solid surface (rigid, chemically inert and not soluble) (Fig. 19). In general,
if a surface has a θc < 90º it is considered hydrophilic, but if the θc > 90º is considered
hydrophobic [58].
The surface wettability of samples was evaluated with a water contact angle
goniometer (KSV CAM-101) used on the static sessile drop mode: a 5μL drop of water
was applied onto the sample surface and the contact angle formed with the surface was
measured. Each measurement was repeated five times. The statistical data obtained were
processed by Statgraphics Centurion XV.
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Figure 19. a) Hydrophilic surface, and b) hydrophobic surface.
iv) Toluidine Blue Ortho (TBO) titration
Toluidine blue ortho (TBO) (Fig. 20) is a cationic (basic) dye that interacts
electrostatically with negatively charged groups and can be easily detected by light
absorption in the blue region. By means of titration, it is currently employed in a variety
of applications as a labeling agent, photosensitizer, or mediator for chemical reactions,
but is used especially in the medical field to mark or target acidic compounds using high
pH solutions [59].
Figure 20. TBO molecule, a cationic dye.
As PSi/CD hybrids presents free carboxylate groups carried by the citrate
crosslinks, the carboxylic group density on samples (μmol COOH/cm2 and μmol
COOH/mg) was calculated using TBO titration [60]. Samples were submerged into a 0.5
mM TBO (Aldrich) solution (pH 10, adjusted by NaOH) at 30 ◦C for 4 h. Non-
complexed TBO was rinsed with 50 mL of 0.1 M NaOH for 2 min. Complexed TBO was
θC θC
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desorbed from samples with 10 mL of 50% (v/v) acetic acid for 30 min. The desorbed
TBO in acetic acid was quantified by UVvisible spectrophotometry (UV-1800
spectrometer, Shimadzu) at 634 nm and the density of COOH functions was calculated
according to a mole-to-mole complex between TBO and accessible COOH groups [59].
v) Thermogravimetric Analysis (TGA)
According to Brown [61], a thermal analysis “monitors the change in a property of
a sample, which is related to an imposed temperature alteration”. In the case of
thermogravimetric analysis (TGA), changes in weight are measured as a function of
increasing temperature [62]. TGA provides information related to the physical and
chemical phenomena listed in Table 5.
Table 5. Related information of physical and chemical phenomena provided by TGA [62].
Physical phenomena Chemical phenomena
Fusion Chemisorption
Vaporization Desolvation (especially dehydration)
Sublimation Decomposition
Absorption Oxidative degradation
Adsorption Solid-state reactions
Desorption Solid-gas reactions (i. e. oxidation, reduction)
The TGA technique was used in the characterization of PSi/CD hybrids, which
was performed in a TA-Q50 apparatus (TA Instruments) to determine the quantity of
organic polyCD fixed onto the PSi samples. Measurements were recorded in the 30-
700°C temperature range with a heating rate of 10°C/min in a 90% O2-10% N2
atmosphere. The used equipment was installed in UMET, Université Lille 1.
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vi) X-ray Diffraction (XRD)
X-ray diffraction (XRD) is a technique primarily used to characterize the
crystalline components of a material [63]. XRD is most widely used for identification of
crystalline phases, preferred crystal orientation, periodicity and symmetry of a crystal,
grain size, strain and crystal defects. In a typical XRD analysis a monochromatic Cu-Kα
radiation (λ = 0.154 nm) is incised at a θ angle (0-90º) on a sample and the diffracted
intensity is detected at a 2θ angle. The fundamental of XRD is based on the pattern
generated by the X-rays diffracted by the atomic planes of the crystal (Fig. 21-b). This
phenomenon is described by the Bragg’s law.
The Bragg’s law relates the incident X-ray angle to a length in real space [64]:= (Eq. 6)
where dhkl is the distance between the atomic planes; n is an integer number; λ the X-ray
wavelength and θ is the X-ray angle of incidence.
Figure 21. Schemes of the Bragg’s law.
The crystalline structure of PSi/CaP bioceramics was determined by glazing angle
X-ray diffraction (GA-XRD) with a Siemens D5000 diffractometer using Cu-Kα
radiation (λ = 1.54 Å). The analysis was performed at a fixed angle of 0.5º from θ= 10º to
θ= 60º with increments of Δθ= 0.04º and accumulation times of 8 s. The glazing angle
mode was selected because is more sensitive to particles deposited on a surface. GA-XRD
measurements were carried out in SIdI facilities.
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vii) Ultraviolet-visible Spectroscopy (UV-Vis)
For liquid systems, ultraviolet-visible spectroscopy refers to the use of light in the
ultraviolet/visible range to measure chemical concentrations [65]. When a molecule that
contains valence electrons of low excitation energy absorbs UV-Vis radiation, the
electron energy is promoted to an excited state. This produces a continuous absorption
band, which results in different possible electronic transitions. The electron transitions for
n, , and  bonding orbitals are shown in Fig. 22.
Figure 22. Absorption of light increases the energy of a molecule.
The absorbance (A) is defined as [65]:= − (Eq. 7)
where I0 is the intensity of the radiation before it passes through the solution (incident
radiation); and I is the intensity of the radiation after passing through the solution. In Fig.
23, a scheme of a double beam UV-Vis spectrophotometer is illustrated.
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Figure 23. Schematic diagram of a double-beam UV-Vis spectrophotometer.
An UV–visible spectrophotometer (UV-1800 spectrometer, Shimadzu) was used
for the elaboration of drug release profiles (Section 2.2.3) according to protocol from
UMET of Université Lille 1. The spectrophotometer was used under the absorption mode
in the range of wavelength of light from 300 to 200 nm with a resolution of 1 nm.
viii) Energy Dispersive X-ray Spectroscopy (EDX)
Energy Dispersive X-ray Spectroscopy (EDX) is an analytical technique used for
the elemental analysis or chemical characterization of a sample. Usually, it is
incorporated to a SEM microscope. When an electron beam (at 10 keV) collides with
the sample (Fig. 24), it creates a vacancy in an atomic inner level due to an electron
displacement from K-shell. Then, the vacancy is filled by an electron from an upper shell,
which induces a dissipation of energy in the form of a characteristic X-ray emission from
the element involved in the transition [16].
The EDX equipment used was an INCA X-sight from Oxford Instruments within
the SEM of SIdI.
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Figure 24. Scheme of the X-ray emission in EDX.
ix) Fourier Transform Infrared Spectroscopy (FTIR)
Fourier Transform Infrared Spectroscopy (FTIR) is a technique mainly used to
detect functional groups in a molecule. Although it can be used for both qualitative and
quantitative analysis, it is most commonly used as a qualitative technique. FTIR is a
technique based on measuring the power density and the optical path, which forms a
Fourier pair with the light intensity and the wave number of the electromagnetic radiation
[54]. In Fig. 25, a Michelson interferometer system is schematized. The beam from the
infrared source is incident on a splitter, where the beam is divided into two parts. The
reflected part is directed to a sliding mirror, which allows varying the optical path. The
transmitted beam is reflected to a fixed mirror, which carries both beams into a current
signal to the detector. Thus, by varying the optical path is possible to obtain the
interference pattern.
When the sample is incised by IR, the beam produces on the molecule vibrations
and/or rotations causing a net change in the dipolar moment. In turn, the alternating IR
interacts with fluctuations in the dipolar moment of the molecule. When the IR frequency
matches the molecule vibrational frequency, the radiation is absorbed causing a change in
the amplitude of molecular vibration [66]. Typical molecular vibrations are shown in Fig.
26.
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Figure 25. Schematic representation of a Michelson interferometer system.
Figure 26. Main molecular vibrations induced by infrared excitation.
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Two modes of FTIR were used to characterize the composites: in attenuated total
reflectance (ATR-FTIR) for PSi/CD hybrids and in specular reflection (SR-FTIR) for
PSi/CaP bioceramics. In the ATR mode the IR beam is passed through a crystal resulting
in an evanescent wave which penetrates the sample around 0.5 m. In the SR mode, the
IR incident angle is the same of the IR reflected angle. The ATR-FTIR spectrometer
(Spectrum One, Lita detector, MIR source) was facilitated by UMET, which was used in
the range between 4000 and 650 cm-1 with a resolution of 1 cm-1 (NS = 4). The SR-FTIR
measurements were carried out in a Brücker spectrometer mod. IFS 60v (4 cm-1
resolution, 7000-550 cm-1 range) of SIdI facilities.
x) X-ray Photoelectron Spectroscopy (XPS)
X-ray Photoelectron Spectroscopy (XPS) is a surface-sensitive technique probing
at an average depth of 2–6 nm, depending on the material [67]. It is used to measure
elemental composition, and electronic states of the elements that exist within a material.
XPS is based on the photoelectric effect in which the interaction of an X-ray photon of
sufficient energy with a solid results in the emission of an electron from its surface [63].
The fundamental energy conservation equation in photoemission is the following [67]:ℎ = + +Φ (Eq. 8)
in which h is Planck’s constant; v is the photon frequency; EbinF is the binding energy
relative to the Fermi level or electron potential; Ekin is the kinetic energy of the emitted
electron; and 0 is the work function of the spectrometer used to measure kinetic energy.
If the electron’s kinetic energy is measured, and the spectrometer work function is known,
it is possible to measure the binding energies of various inner (or core) electrons, as well
as those of the outer (or valence) electrons (Fig. 27).
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Fig. 27. Schematic view of the photoemission process in the single-particle picture. Electrons with binding
energy EB can be excited into free-electron states above the vacuum level Evac by photons with energy hν >
EB + Φ0. The photoelectron distribution I(Ekin) can be measured by the analyser and is – in first order – an
image of the occupied density of electron states N(EB) of the sample [68].
The PSi/CD hybrids were characterized in detail by XPS technique at the Institute
for Health and Consumer Protection of Joint Research Centre in Ispra, Italy.
Measurements have been performed with an AXIS ULTRA Spectrometer (KRATOS
Analytical, UK). The samples were irradiated with monochromatic AlKα X-rays
(h=1486.6eV). The area of analysis was 400x700 μm2 and the take-off angle (TOA) was
fixed at 90° with respect to the sample surface. Pass energies of 160 eV and 20 eV were
used for the survey and core level spectra, respectively. A filament (I = 1.9 A, V = 3.2 V)
inserted in the magnetic lens system acts as neutralizer for surface charge compensation.
All core level spectra were shifted to a common binding energy of the hydrocarbon
component of the C1s spectrum at 285.0 eV. The data were processed using the Vision2
software (Kratos, UK) and CasaXPS v3.15 (Casa Software, UK).
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xi) Hard X-ray Photoelectron Spectroscopy (HAXPES)
Hard X-ray photoelectron spectroscopy (HAXPES) is an emerging non destructive
technique to determine the chemical and electronic properties of surfaces, buried
interfaces and bulk of solid materials reaching in some cases until 25 nm at 15 keV
depending on the material [69]. As typical energies involved in conventional XPS are
between 40 and 2 000 eV, its analysis is limited to material surfaces. This is because of
the low electron inelastic-mean-free-path (IMFP) and/or the effective attenuation length
(EAL) obtained in the solid materials at that energies. However, by means of HAXPES as
excitation source, high kinetic energy photoelectrons can be produced and macroscopic
penetration depth in the materials can be obtained [70]. Consequently, HAXPES benefits
over conventional XPS, due the exceptionally large escape depth of high kinetic energy
photoelectrons enabling the study of bulk and buried interfaces up to depths of several
tens of nanometres.
In HAXPES, the photoemission intensity for photoelectrons of a q-ionization-sub-
shell produced from a constituent element A located between depth ZA and ZB of a
laterally (x,y) homogeneous sample, within the analyzed area is [70]:(ℎ , ) =( ) ( )( ) ( , ) ∫ ( ) − ( ) (Eq. 9)
where C is the ratio between the X-ray irradiated area and the analyzer area; f(Ehv) is the
intensity of the incident X-rays; Aq(Ehv) is the photoionization cross-section; Γ(Ekin) is
the detector transmission function which depends on the kinetic energy of the
photoelectrons; P is the correction factor for the angular anisotropy of the photoemission
process; EAL is the effective attenuation length of the photoelectrons; nA(z) is the density
profile with depth and θ denotes the angle between the collection direction and the
surface normal. The photoemission process scheme in Fig. 27 is also valid to HAXPES.
PSi/CaP bioceramics made by CEA were characterized by HAXPES. The
analyses were performed at the Spanish CRG SpLine beamline (BM25) of the ESRF,
Grenoble, France [70], using a sector of a cylindrical mirror analyzer (HV-CSA300)
enabling working in a very broad kinetic energy range (from few eV up to 15 KeV). A
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two dimensional event counting detector was used in combination with the CSA analyzer
to reduce the counting rate. The analyzer was used with a constant energy resolution of 1
eV in order to enhance the analyzer transmission and to measure the photoemission
spectra in few minutes. The overall instrumental energy resolution results from the
convolution of the analyzer resolution with the x-ray bandwidth. A double crystal
monochromator equipped with Si (1 1 1) crystals was used providing an energy resolution
of_E/E = 1.5×10−4. Photon energies from 8.5 to 15.5 keV were used to excite Ca 1s, P 1s
and Si 1s signals of the samples. The HAXPES measurements were performed in a
geometry in which the direction of the x-rays, the photoelectron direction towards the
analyzer and the surface normal are in the x-ray polarization plane (azimuth angle set to
0º). The photon incident angle was set to 5º with respect to the sample surface. The
electron emission angle was fixed to 15º, on the forward direction, from the normal to the
sample surface. Hence the angle formed between the x-rays direction and the analyzer
was 100º. The data were processed using the OriginPro 8 and XPS PEAK 4.1 software.
xii) Rutherford Backscattering Spectroscopy (RBS)
Rutherford Backscattering Spectroscopy (RBS) is a technique used to determine
the elements present in a given sample, their stoichiometry, and their depth distribution
[71]. In a RBS analysis (Fig. 28), the sample under study is bombarded with a
monoenergetic beam of ions (i. e. H+ or 4He+ at  MeV) and backscattered particles are
analized by a detector system which measures their energy [9].
Fig. 28. Schematic representation of the experimental setup for RBS analysis.
θ
Incident particles
Scattered particles
Detector
Scattering angle
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When the incident ion collides with an atom at rest from the sample, part of the
incident ion energy is transferred to the target atom receding into the material by the
impact effect. The collision between particles is elastic, so, the energetic balance after
collision depends on the masses of incoming and target atoms. From the equations of
classical kinematics it is possible to determine the fraction of energy which retains the ion
after collision [9]: = (Eq. 10)
= (Eq. 11)
where Ef is the residual energy of the particle scattered (m1) at angle θ; k is the kinematic
scattering factor, which is actually the energy ratio of the particle before and after the
collision; and E0 is the energy of the target atom (m2).
RBS was used to quantify the Ca/P atomic ratio of PSi/CaP bioceramics made by
CEA. The technique was performed using the 5 MeV terminal voltage HVEE tandetron
accelerator of Centro de Microanálisis de Materiales (CMAM) [72]. The analysis was
performed at oxygen resonant energies (resonant RBS) at an energy of 3.035 MeV by a
4He+ ion beam. The corresponding simulations were carried out using the software
SIMNRA 6.05 [73].
2.3.3 In vitro biological assays
The in vitro biological assays were carried out by means of cell culturing. A cell
culture is the removal of cells from an animal or plant and their subsequent growth in an
artificial environment [74]. The primary culture is the stage after cells are isolated from
the tissue and proliferated under the appropriate conditions until they occupy the entire
available substrate. Moreover, the subculture is the cell transferring to a new substrate
with fresh growth medium for continued growth.
This technique is one of the major tools used in cellular and molecular biology for
the study of:
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 physiology and biochemistry of cells;
 the effects of drugs and toxic compounds on the cells;
 mutagenesis and carcinogenesis;
 drug screening and development of biological compounds.
Two kinds of cells were used to test the biocompatibility of PSi-based composites:
L132 cells on PSi/CD hybrids and human mesenchymal stem cells (hMSCs) on PSi/CaP
bioceramics.
i) L132 Cells
L132 cells are the human embryonic lung cell line [75] successful used to test the
biocompatibility of prosthesis [76]. A cell line, or subclone, is derived from the primary
culture after the first subculture [74]. As they have a limited life span and are transferred,
cells with the highest growth capacity predominate, resulting in a degree of genotypic and
phenotypic uniformity in the population, which are used to evaluate the biocompatibility
of materials. L132 cells grown on commercial materials are show in Fig. 29.
Fig. 29. SEM images of L132 cells grown on: a) control substrate; b) Melinex®; c) Polythese®;
d) Polymaille®; e) Polythese® functionalized with a cyclodextrin polymer; and f) Polymaille®
functionalized with a cyclodextrin polymer (from Blanchemain et al. [76]).
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The cytocompatibility of the PSi/CD hybrids was evaluated by L132 cell culture
according to the protocol of Groupe de Recherche sur Biomatériaux in Université Lille 2.
First, cells were cultured in Eagle's minimum essential medium (MEM, ATCC®) with
glutamax (Gibco BRL) supplemented with 10% fetal calf serum (FCS, Gibco); 50 µg/mL
gentamicin (Gibco) and 1 µg/mL amphotericin B (Gibco). Later, cells were incubated at
37°C and 5% CO2 atmosphere and 100% relative humidity. The cells in the phase of
exponential growth were seeded on the samples and cultured for 24 h. For the observation
of cell adhesion and cell morphology with SEM, the samples were fixed with 2.5%
glutaraldehyde in 0.1 M sodium phosphate buffer (pH 7), then washed twice in 0.1 M
sodium phosphate buffer. Thereafter, the samples were post-fixed with 1% osmium
tetroxide (OsO4) in saturated HgCl2 to obtain the best cell morphology. After a graduated
dehydration in ethanol, the samples were critical-point dried with CO2 and examined in a
J-SM-5300 SEM (Jeol), operated at 30 keV.
ii) Human Mesenchymal Stem Cells (hMSCs)
Human Mesenchymal Stem Cells (hMSCs) are multipotent cells present in adult
marrow [77]. They can replicate as undifferentiated cells, but have the potential to
differentiate to lineages of mesenchymal tissues such as bone, cartilage, fat, tendon,
muscle, and marrow stroma. In general, mesenchymal stem cells can be used to study the
biocompatibility and bioactivity of materials designed to orthopaedic and dental
applications [78]. In Fig. 30, a hMSCs image taken by fluorescence microscopy is shown.
The biocompatibility of PSi/CaP bioceramics was tested by hMSCs culture
according to Muñoz et. al. [79] in the Departamento de Biología Molecular, Universidad
Autónoma de Madrid. Cells were isolated from human bone marrow samples and
collected by centrifugation on 70% Percoll gradient and seeded at 200,000 cm2 in
DMEM-LG (Gibco) supplemented with 10% fetal bovine serum (FBS, Sigma). Before
conducting any cell culture, phosphate buffered saline (PBS) rinsing and UV exposure
were used to sterilize composite materials used in this study. Then, samples were placed
on 24-multiwell plates, 15000 cells were seeded in each well and incubated with DMEM-
LG supplemented with 10% FBS for 24h at 37°C for conducting hMSCs adhesion studies.
For in situ immunofluorescence, cells were rinsed twice with PBS and fixed with 3.7%
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formaldehyde in PBS during 15 min for further actin and nuclei staining. Cytoskeleton
was permeated by incubating in a buffer containing 10-2 M Pipes pH 6.8, 3.10-3 M MgCl2,
10-1 M NaCl, 10-3 M EGTA, 0.3 M sucrose and 0.5% triton X- 100 for 30 min at room
temperature. Then, samples were washed with PBS. In order to block materials surfaces,
1% bovine serum albumin in PBS for 1 h at room temperature was used. Actin was
stained by phalloidin-Alexa 488 at 1:100 v/v dilution (Molecular Probes) and nuclei were
stained with Dapi diluted 1:5000 v/v (Calbiochem) in dark conditions for 45 min. Finally,
cells were visualized in an inverted fluorescence microscope (Olympus IX81) coupled to
a CCD colour camera.
Fig. 30. Fluorphore labeled hMSCs grown on a gelatin-covered glass control (DAPI-stained nuclei, Alexa
488 phalloidin stained actin, from Muñoz et al. [79]).
2.3.4 Drug release profiles
Drug delivery systems release a drug in a controlled manner, at a predetermined
rate for a definite time period [80]. A potentially usefull method to monitor the drug
release kinetic is by UV-Vis spectroscopy [81] (section 2.2.2-vii), because of the
absorbance is directly proportional to the concentration of the light-absorbing species in
the sample:
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= (Eq. 12)
where Aλ is the absorbance at a wavelength; ε is the molar absorptivity at a particular
wavelength; b is the pathlength; and c is the concentration of the sample. Then, the
release profile can be obtained from calculated concentrations at different times (Fig. 31).
Fig. 31. Examples of absorbance spectra at different time of drug release.
The kinetic studies of PSi/CD hybrids as drug delivery systems were analyzed by
drug release profiles done according to UMET protocol. Samples were loaded with
ciprofloxacin-base (CFX, an antibiotic) and prednisolone (PDN, an anti-inflammatory)
(both in Fig. 32), by means of a saturated aqueous solution of each drug (60 mg/L and 2
g/L, respectively) for 24 h stirring at 100 rpm. In order to check the maximum drug
loading, samples were hydrolyzed by stirring for 24 h in 0.1 M NaOH solutions that were
analyzed by UV–visible spectrometry [82] (UV-1800 spectrometer, Shimadzu). CFX was
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detected at 275 nm and the PDN at 245 nm. Drug release data were collected at different
times in two different media: distilled water and PBS, both in agitation at 100 rpm.
Figure 32. Scheme of: a) CFX, ciprofloxacin; and b) PDN, prednisolone.
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Chapter 3:
PSi/Cyclodextrin
Drug Delivery Hybrids
3.1 Introduction
The harmful side effects of pharmaceuticals within the body continuously calls for
the development of new carriers and devices for drug delivery ideally allowing a
sustained and localized release [1]. In particular, the delivery of drugs to the posterior eye
is still a challenge, owing to anatomical and physiological constrains of the eye. Thus,
various controlled drug delivery systems, such as biodegradable and non-biodegradable
implants, liposomes and nanoparticles, have been developed as new therapeutic
techniques for diseases of the posterior segment of the eye [2]. The routes to deliver
pharmaceuticals can be topical, systemic, intravitreal and periocular [2].
The cyclodextrins (CDs) have been used as efficient delivery carriers due to their
characteristic cavity and their ability to form reversible complexes with drugs [3]. Using
citric acid as crosslinking of CDs it is possible to synthesize a three-dimensional polymer
network suitable for drug delivery applications, prolonging the residence time in the
medium and/or increasing efficiency and specificity towards targeted sites [4]. Besides, in
order to improve control over drug release kinetics and stability in aqueous media, CD-
based polymers could be combined with PSi as a composite [5]. After a stabilization
treatment of the surface by H2O2 oxidation, PSi could be suitable biomaterial to use as a
substrate for CD-based polymer for drug delivery applications.
In this context, PSi/CD drug delivery hybrids have been developed for the
treatment of postoperative endophthalmitis (POE). POE is the severe inflammation
involving both the anterior and posterior segments of the eye derived from an infectious
agent after an eye surgery [6]. This complication may arise from any surgical procedure
that disrupts the integrity of the globe including cataract surgeries, radial keratotomy,
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retinal surgeries, and glaucoma filtering surgeries [6]. POE may be originated by the
characteristic ocular inflammation after an eye surgery [7] or by a postoperative bacterial
infection [8]. POE may cause postoperative pain and photophobia, but its complications
may result in increased intraocular pressure, posterior capsular opacification, cystoids
macular edema, and decreased visual acuity [7]. The proposed hybrids could be
intravitreally injected during any eye surgery in order to reduce POE complications (Fig.
1). Other common intravitreal systems of drug release are vitreous humour and scleral
implants, which are also schematized in Fig 1.
Figure 1. Scheme of the intravitreal route of drug administration to the posterior eye: A) micro- or
nanoparticles injected using a needle, B) biodegradable or non-biodegradable implants surgically
introduced into the vitreous humour and, C) scleral plugs or implants sutured onto the sclera (from
Thrimawithana et. al. [2]).
The hybrids proposed in this chapter consist of the functionalization of
nanoporous or macroporous PSi (nPSi or mPSi, respectively) by β-cyclodextrin–citric
acid in-situ polymerization. Samples are chemically, morphologically and biologically
studied by means of different techniques, and their functionalization degree is assessed.
Finally, in order to test them as potential intraocular drug delivery systems [9], hybids are
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loaded with two drugs used in post-ophthalmic surgery (Fig. 2): ciprofloxacin (CFX, an
antibiotic) [10,11] and prednisolone (PDN, an anti-inflammatory) [12,13].
Figure 2. Scheme of PSi/cyclodextrin hybrids as drug delivery systems.
3.2 Materials and Methods
3.2.1 Synthesis of PSi/cyclodextrin hybrids
nPSi or mPSi were used as substrates for the fabrication of the hybrids. nPSi was
synthesized using a current density of 60 mA/cm2 for 90 s (Section 2.2.1 –ii of Chapter 2).
A 60% porosity was calculated by gravimetric analysis. mPSi was fabricated with a
current density of 20 mA/cm2 for 600 s (Section 2.2.1 –iv of Chapter 2). The porosity
calculated for mPSi was 40%. Both substrates were chemically oxidized with H2O2 (nPSi-
COx and mPSi-Cox), rinsed with EtOH and dried under a nitrogen stream. nPSi-COx and
mPSi-COx were functionalized by β-cyclodextrin–citric acid polymer (polyCD)
according to the protocol described in Section 2.2.2 –iii of Chapter 2.
3.2.2 Characterization techniques
Synthesized hybrids were characterized by chemical techniques (ATR-FTIR, XPS
and water contact angle) and microscopies (AFM and SEM/FESEM). Their degree of
functionalization was tested by TGA and TBO titration (see Sections 2.3.1 and 2.3.2 of
Chapter 2). The biocompatibility of the hybrids was tested by in vitro culture of the
human epithelial cell line (L132). Finally, both systems were tested as drug delivery
platforms with the drugs, CFX and PDN, in two media: pure water and phosphate buffer
saline (PBS) solution.
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3.3 Results and Discussion
3.3.1 Chemical characterization of PSi functionalization by polyCD
In this section we focus on the characterization of the chemical composition of
fresh (recently synthesized PSi), oxidized (stabilized PSi), and functionalized samples
(PSi hybrids) based on both nPSi and mPSi.
ATR-FTIR spectra are shown in Fig. 3. Spectra plotted in Fig. 3a correspond to
nano- series. The spectrum of nPSi shows absorbance peaks at 2141, 2115, and 2090 cm-1,
which are attributed to Si-Hx (x=1, 2, 3) stretching modes, respectively [14]. The peak
assigned to SiH2 scissor mode was also detected at 906 cm-1 [15]. As it was mentioned in
Section 2.1.1–vi of Chapter 2, Si-H bonds are characteristic of fresh PSi. After chemical
treatment (nPSi-COx), the peaks corresponding to Si-H bonds transformed to peaks
assigned to surface -OySi-Hx, due to oxidation process at 2250 cm-1 for stretching mode
and at 880 cm-1 for bending mode [14,15]. Besides, a weak band at 835–795 cm–1 from
the Si–OH bond can be observed [16] as well as the O-H stretching band from SiOH
groups at 3350 cm-1 [15]. Absorbance peaks related to surface Si-O-Si stretching mode at
1170 and 1060 cm-1 are also observed [14,15]. These results are in agreement with the
transformations proposed in Eq. 2 of Section 2.1.1-vi in Chapter 2.
Nanoporous samples functionalized with polyCD (nPSi-CD) exhibit the same
peaks as pure polyCD. The main absorbance peaks corresponding to bond vibrations from
polyCD [17,18] can be observed: O-H stretching from hydroxyl and carboxyl groups
(3435 cm-1), CH2 asymmetric stretching (2933 cm-1), C=O stretching (1736 cm-1), C-O-C
stretching (1155 cm-1) and the C-OH stretching (1026 cm-1). This indicates that nPSi
presented a properly adhered polymerized film.
Spectra of macroporous samples are plotted in Fig. 3b. In the spectrum
corresponding to mPSi a weak band related to Si-H bonds from fresh PSi [19] is
appreciable at 2100 cm-1. In this case, the band can be decomposed into three components
near 2140, 2110 and 2080 cm-1 [19]. Nevertheless, the main absorption peaks correspond
to Si-O-Si at 1108 cm-1 and 870 cm-1 [14,20], confirming that mPSi is more susceptible to
oxidation than to hydrogenation during its formation [19,21]. After chemical oxidation,
the Si-H signal faded away, but SiOH groups were not detected. As in the case of nPSi-
CD, mPSi-CD was also well coated with an organic film since the corresponding
spectrum matches the well that of pure polyCD.
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Figure 3. FTIR-ATR spectra of: a) nPSi- series samples: nPSi-Fresh (black line), nPSi-COx (cyan line),
polyCD (black dotted line), nPSi-CD (blue line); and b) mPSi- series samples: mPSi-Fresh (black line),
mPSi-COx (magneta line), polyCD (black dotted line), mPSi-CD (red line).
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Since the XPS probing depth in our experimental conditions is approximately 10-
12 nm, the study of the evolution of the surface chemistry was performed on the nPSi
series samples (the corresponding surfaces are less rough than the mPSi ones, the root
mean square roughness (RRMS) being 1-10 nm, in the order of the scape depth of
generated photoelectrons). The elemental surface composition of nPSi, nPSi-COx and
nPSi-CD was obtained from the XPS survey spectra and are presented in Table 1.
Table 1. Surface chemical compositions of nPSi,
nPSi-COx and nPSi-CD obtained from XPS analysis.
Sample C (at%) O (at%) N (at%) Si (at%) F (at%)
nPSi 22.5 (0.2) 31.6 (0.03) -- 44.9 (0.41) 1.0 (0.2)
nPSi-COx. 2.5 (0.4) 66.2 (0.24) -- 30.7 (0.5) 0.6 (0.1)
nPSi-CD 56.9 (0.5) 43.0 (0.24) -- -- --
It can be seen that the starting nPSi substrate shows C contamination, apart from
the expected Si and O signals. Moreover, a light presence of other surface synthesis
residues, such as F, is also detected. After oxidation, carbon is drastically reduced, whilst
O content increased by a factor of 2.1. This indicates the successful oxidation of the PSi
surface. This result is also confirmed by the analysis of the Si 2p core level spectra (Fig.
4a), where it can be noticed that the doublet at about 99.6 eV (Si2p3/2), corresponding to
the Si0 oxidation state, strongly decreases. In parallel, the other components at higher
binding energies, corresponding to different oxidation states, increase. In particular, for
bare nPSi, three components related to SiO (100.7 eV), SiOX (x<2, 102 eV) and SiO2
(103.6 eV) are identified after deconvolution [22]. After oxidation, the major component
of nPSi-COx is related to the SiO2 groups, which accounts for about 40% of the Si signal
(Fig. 4b). Moreover, the position of the SiO2 peak shifts towards higher binding energies
(0.6 eV with respect to the bare nPSi), indicating the growth of a dense oxide layer [23].
However, it should be also noticed that the intensities of the components corresponding to
lower Si oxidation states and to sub-stoichiometric SiOx bonds also increase after the
oxidation process.
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Figure 4. Si 2p core level XPS spectra of: a) nPSi and b) nPSi-COx.
The in situ polymerization of CD and citric acid further changes the surface
composition (Table 1). In fact the Si signal disappears, the O decreases and the carbon
content increases up to 63 at%. This indicates the successful growth of a uniform and
continuous polymer layer. This result is also corroborated by the C 1s core level spectrum
presented in Fig. 5. The C1s envelope can be fitted with four components corresponding
to C-C/CH (285.00 eV), C-O (286.5eV), C=O/O-C-O (287.5eV) and COOH/R (289.2eV)
[23,24]. The success of this polymerization was supported by the previous oxidation
process, which stabilizes the PSi and makes compatible the interaction with the
polymerized CD`s.
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Figure 5. C1s core level spectra of nPSi-CD.
The samples surface wettability was assessed by the water contact angle technique
(Fig. 6). nPSi showed a hydrophobic behavior and mPSi presented a tendency to
hydrophobic behavior (water contact angle of 126° and 84º, respectively) due to Si-H
surface groups [25]. After chemical oxidation, fresh samples change their wettability into
a strong hydrophilic behavior, 7.7° for nPSi-COx and 14.7° for mPSi-COx, due to Si-O,
H-Si-O [25] and Si-OH bonds [26]. In the case of functionalized samples, the wettability
was practically the same on both (nPSi-CD and mPSi-CD) since the polymer layer has the
same surface composition (Fig. 3). Their contact angles are similar: 31° for nPSi-CD and
33° for mPSi-CD. This tendency of modification is illustrated with images and data in Fig.
6-a and Fig. 6-b, respectively.
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Figure 6. Contact angle technique: a) photographic sequence and b) plotted data.
3.3.2 Microscopic characterization of PSi functionalization by polyCD
In order to study the roughness and topography of the sample surface, AFM
analyses were carried out, while the samples morphology was observed by SEM/FESEM.
AFM images provide relevant information regarding sample surface (Fig. 7). The
analyzed area in all cases was 4 m2. nPSi and nPSi-COx samples (Fig. 7-a1 and 7-a2)
showed a different RRMS: 0.584 nm and 1.050 nm, respectively. This is reflected in the
textured morphology of nPSi-COx surface that is rounder than in nPSi, which may be
attributed to the oxidation post-treatment. In the case of mPSi and mPSi-COx (Fig. 7-b1
and 7-b2) both showed similar values of RRMS: 0.218 μm and 0.251 μm, respectively.
Therefore, they did not show a drastic morphologic change after chemical oxidation.
AFM images of functionalized samples with the polyCD are shown in Fig. 7-a3
(nPSi-CD) and Fig. 7-b3 (mPSi-CD). One can appreciate that the surface of both types of
samples were completely covered by the polymer providing a different topography. They
have similar values of RRMS: 1.89 nm for nPSi-CD and 3.27 nm for mPSi-CD.
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Figure 7. 3D AFM images of a1) nPSi, b1) mPSi, a2) nPSi-COx, b2) mPSi-COx, a3) nPSi-CD and b3)
mPSi-CD.
The Z-profile of samples has been plotted as a complementary visualization of
topographic differences among them (Fig 8). The increase in roughness of nanostructured
fresh samples (nPSi) after the oxidization treatment (nPSi-COx) is clearly and better
observed in Fig. 8-a than their respective 3D AFM images (Fig. 7-a1 and 7-a2,
respectively): nPSi-COx show deeper valleys than nPSi. On the other hand, the close
values of surface roughness of macroporous samples (mPSi and mPSi-COx) and
functionalized samples (nPSi-CD and mPSi-CD) are also proved with their respective Z-
profiles, because they have a similar valley depth (Fig. 8-c).
μm
a1 b1
a2 b2
a3 b3
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Figure 8. Comparative Z-profile of samples: a) nPSi vs nPSi-COx, b) mPSi vs-mPSi-COX, and c) nPSi-CD
vs mPSi-CD.
In order to complement the study on the morphology of synthesized samples,
SEM/FESEM analyses were carried out. No significant morphological differences
between non-oxidized samples and oxidized samples were detected. The FESEM images
of oxidized samples, nPSi-COx and mPSi-COx, are shown in Fig. 9. One can observe that
nPSi-COx layer has a thickness of 3.4 m and an average pore diameter of 30 nm (Fig. 9-
a1 and Fig. 9-a2, respectively). In the case of mPSi-COx, the thickness is 7.1 m and the
pore diameter around 1 m (Fig. 9-b1 and Fig. 9-b2, respectively).
SEM images of functionalized samples are shown in Fig 10. The synthesized
polymer layer on the top surface of both samples has the same thickness (approximately
2.5 m) and it also infiltrates into the porous matrix of samples (Fig. 10-a1 for nPSi-CD
and Fig. 10-b1 for mPSi-CD). The top view of nPSi-CD and mPSi-CD (Fig. 10-a2 and
Fig 10-b2, respectively) illustrate that the polymer coating is homogeneous and very
similar in both cases, showing some cracks on their surface. On the other hand, cross-
sectional SEM images (Fig. 11) show that both polymerizations are homogeneously well
formed over the substrates.
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Figure 9. FESEM images of nPSi-COx, cross-section (a1) and top view (a2); and
mPSi-COx, cross-section (b1) and top view (b2).
Figure 10. SEM images of nPSi-CD, cross-section (a1) and top view (a2); and
mPSi-CD, cross-section (b1) and top view (b2).
a1
b1
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Figure 11. Zoom out SEM images in cross-section of: a) nPSi-CD and b) mPSi-CD.
From the previous chemical and microscopic characterization results, it is possible
to explain the binding between the PSi structures (nano- and macro-) and the polyCD.
Two phenomena are mainly involved; one chemical, the hydrophilic compatibility of
oxidized PSi samples with the external wall of CD’s that is full of OH bonds [27], and
other physical, the porosity of samples works as an anchor holding the polymer film (Fig.
7 and Fig. 10).
3.3.3 Degree of PSi functionalization by polyCD
In order to evaluate the functionalization degree in PSi/CD hybrids, TGA and
gravimetric measurements were performed. Firstly, the thermogravimetric analysis of the
polyCD was monitored as reference (Fig. 12). The polymer decomposition is clearly
appreciable. The first stage starts at around 200°C reaching the maximum peak around
300 °C where a dominant part of the glucose units are melted, decomposed and turned
into char [28]. The last narrow peak is identified at around 475 ºC and is associated to the
degradation of this char residue [28].
a) b)
Si substrateSi substrate
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Figure 12. Thermogravimetric analysis of a polyCD control.
The results of thermogravimetric analysis of hybrids are shown in Fig. 13. The
plot in Fig. 13-a corresponds to the nano- sample series. The solid lines indicate the
weight (left axis) as a function of temperature and the dotted lines its derivative (right
axis). In the case of nPSi-COx, one can observe that mass increases with temperature.
This is because of oxygen incorporation to the sample by thermal oxidation induced
during TGA. This confirms that nPSi chemical oxidation by H2O2 is a partial surface
oxidation [16]. Nevertheless, the phenomenon is gradual with the derivative curve
monotonically growing at decreasing rate. On the other hand, the polymer decomposition
in nPSi-CD is noticeable. As in the case of the reference, the phenomenon starts at 200 °C,
reaching the maximum peak around 300 °C where glucose is decomposed into char.
Nevertheless, the last stage associated to char degradation is produced at a lower
temperature (435 ºC). TGA results from macro- sample series are plotted in Fig. 13-b.
One can observe that mPSi-COx acquired less mass than nPSi-COx, this is due to a lower
oxidation in this sample associated to the lower surface density. The mPSi-CD sample
shows a similar behavior than nPSi-CD with the two important stages: one starting at
around 200 °C, which reached the maximum at 300 ºC, and other at 450 ºC, which is also
observed at lower temperature than for the reference sample. Although TGA analyses of
functionalized samples revealed differences with respect to the reference, they denote the
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presence of β-cyclodextrin and citric acid in both hybrids. The shift to lower temperatures
of the char degradation in both hybrids could be due to the increasing of surface area in
PSi substrates. A larger surface area facilitates heat transfer and thus nPSi-CD exhibits a
lower char degradation temperature than mPSi-CD.
Figure 13. Thermogravimetric analysis of: a) nPSi- samples and b) mPSi- samples before and after CD
modification. The solid lines indicate the weight (left axis) and the dotted lines its derivative (right axis).
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In order to measure the functionalization degree of polyCD onto the oxidized
samples (nPSi-COx and mPSi-COx), it was necessary to remove the contribution of the
silicon substrate to total weight (see Fig. 11). This was achieved by gravimetric
measurements and TGA. The surface densities and calculated fixed polymer amounts are
shown in Table 2. Results indicate a surfacic weight increase from oxidized samples to
the functionalized ones from 0.49 to 1.16 mg/cm² (+136.74%) and from 1.79 to 2.64
mg/cm² (+47.79%) for nPSi and mPSi samples respectively. The estimated differences of
polyCD were 0.67 and 0.85 mg/cm², respectively. So the polymer composition per
surface area of PSi (mg/cm2) was 1.27 times higher in mPSi-CD compared to nPSi-CD. A
reverse proportion was observed if the weight of polyCD is considered per unit of weight
of nPSi and mPSi. The values were 1.37 and 0.47 mg/mg, respectively (rightmost column
of Table 2). Thus, the ponderated composition of nPSi-CD in polyCD was 2.91 times that
of mPSi-CD. This result can be attributed to the large difference of surfacic mass between
both support materials (leftmost column of Table 2).
Table 2. Surfacic mass and polymer amounts calculated from TGA.
Sample mg PSi
/cm2
mg polyCD-PSi
/cm2
mg polyCD
/cm2 PSi
mg polyCD
/mg PSi
nPSi- 0.49 (±0.03) 1.16 (±0.08) 0.67 (±0.04) 1.37 (±0.09)
mPSi- 1.79 (±0.14) 2.64 (±0.21) 0.85 (±0.07) 0.47 (±0.04)
The amount of immobilized polymer on PSi surfaces was also indirectly measured
by detecting –COOH groups by TBO titration (Fig. 14). Data were reported as a function
of area and mass of the composite, that is to say, the polymer and PSi considered as a
whole (for nPSi-CD and mPSi-CD). The TBO loaded normalized to PSi surface area in
mPSi-CD (0.975 μmol/cm2) more than doubled that in nPSi-CD (0.463 μmol/cm2) but the
load normalized to PSi mass was almost the same in both cases; just 8% more in nPSi-CD
(0.40 μmol/mg) with respect to mPSi-CD (0.37 μmol/mg).
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Figure 14. The TBO loaded into different PSi supports according to: a) PSi surface area normalization
(μmol/cm2) and b) PSi mass normalization (μmol/mg).
3.3.4 Biological evaluation
The cytocompatibility of the PSi-CD samples was tested in-vitro by studying the
adhesion of L132 cells after 24 h of culture (Fig. 15). The cells adhered to the surfaces of
all samples, giving a first positive estimation of biocompatibility [29]. However, the
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adherent cells on the samples also presented strong differences in morphology, indicating
that the evolution of cells in terms of cell growth in longer culture experiments might be
considerably different [30]. On nPSi, SEM images show that cells were isolated and
presented a contracted semispherical form (Fig 15-a1). Besides, few and short filopodia
were observed (white arrows in Fig. 15-a2). These two characteristics denote that the
cells did not fully-adhere on the substrate [31]. In the case of cells on nPSi-CD, cell
bodies were oval with extended lamellipodia (Fig. 15-b1). Around their body, numerous
filopodia were extended anchoring the cell to the surface (white arrows in Fig. 15-b2).
Those signs imply a better adhesion to the surface and their elongated cytoskeleton can be
interpreted in terms of a migratory state [31]. Cells on mPSi were spread and closely
contacted to the surface (Fig. 15-c1). Moreover, some filopodia are observed in the
higher-magnification image in Fig. 15-c2 (white arrows), which confirms that mPSi is
better suited to support cells than nPSi [32]. Finally, it was found, in the case of mPSi-CD,
that the polymer coating layer on the top surface was not strong enough to resist the cell
culture or process of SEM sample preparation. The top polymer layer peeled off from the
substrate (inset SEM image of Fig. 15-d1) and probably carried away the adherent cells.
Consequently, the cells were observed only in restricted areas of the sample. Relevantly,
in spite of the absence of the top polyCD layer, there were pores refilled with polymer
remnants. The cells were drastically elongated under this materials configuration and
slightly repelled substratum in their central area, minimizing the contact with the surface
(Fig. 15-d1). Although there were no observable filopodia (Fig. 15-d2), their long
stretched shape suggest again a migratory state [25].
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Figure 15. SEM images of L132 cells after 24 h culture on: nPSi (a1 and a2),
mPSi (b1 and b2), nPSi-CD (c1 and c2) and mPSi-CD (d1 and d2).
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3.3.5 Study of drug delivery
In order to test the layered hybrids as potential intraocular drug delivery system,
the samples were loaded with the ophthalmic drugs CFX and PDN (see Fig. 30 of Section
2.2.3 in Chapter 2).
The elemental surface compositions of the nPSi-CD before and after drug loadings
was obtained from the XPS survey spectra and are presented in Table 3.
Table 3. Surface chemical compositions of nPSi-CD
obtained before and after drug loadings from XPS analysis.
Sample C (at%) O (at%) N (at%) Si (at%) F (at%)
nPSi-CD 56.9 (0.5) 43.0 (0.24) -- -- --
nPSi-CD-CFX 61.5 (0.3) 31.6 (0.2) 4.5 (0.24) 0.4 (0.2) 1.4 (0.2)
nPSi-CD-PDN 58.2 (0.6) 40.4 (0.53) 1.1 (0.01) 0.1 (0.02) --
The loading of CFX is demonstrated by the appearance of N and the emerging of
F signals (three and one atoms per CFX molecule, respectively) not detected in the
unloaded samples (Table 3). The analyses show also a slight surface contamination by
silicon and, in the case of nPSi-CD-PDN, also nitrogen. The analysis of the C1s core level
spectrum (Fig. 16-b) further supports this conclusion. In fact, after CFX loading, the
intensity of the hydrocarbon component at 285eV increases slightly. Moreover, the
FWHM of the C1 and C2 components increases indicating the presence of C-N and
CN(O) bonds and also of C-F (expected at about 289.0 eV). In addition, the C3
component shifts toward lower binding energy (about 0.22eV) also supporting the
formation of COO type bonds. On the other hand, in the case of PDN loading, the XPS
analysis is not so indicative of its presence on the surface since there are no additional
elements in PDN to those present on the nPSi-CD surface. However, the increase of the
C3 (C=O) and C0 (C-C) components in the C1s core level spectra (Figure 16-c) are
compatible with an enrichment on PDN in view of the presence of two C=O carbons and
13 C-C carbons in the PDN molecule.
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Figure 16. C1s core level spectra of a) nPSi-CD, b) nPSi-CD after CFX loading and c) nPSi-CD after PDN
loading.
To summarize the whole process of hybrid synthesis and loading, an evolution of
surface chemical composition of samples measured by XPS is shown in Fig. 17. Each
synthesis step is represented: nPSi formation, chemical oxidation, CD polymerization and
drugs loading.
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Figure 17. Evolution of surface chemical composition measured by XPS: a)PSi recently formed, nPSi; b)
after chemical oxidation, nPSi-COx; c) after polymerization; nPSi-CD; d) after CFX loading, nPSi-CD-
CFX; and e) after PDN loading, nPSi-CD-PDN.
In a last step for evaluating the drug delivery functionality of the composites, the
samples were tested with CFX and PDN in water and PBS batches under stirring. CFX
release profiles in distilled water are shown in Fig. 18. The profiles of Fig. 18-a
correspond to the drug release as a function of sample area and the profiles of Fig. 18-b
report the drug release as a function of sample mass. The equivalent profiles obtained in
PBS are shown in Fig. 19-a and Fig. 19-b.
The four release profiles in Fig. 18 and Fig. 19 clearly show that CD-
functionalized PSi samples worked much better than COx control samples. The COx
samples retained a small amount of drug, which was released during the first minutes. In
the case of functionalized samples, the maximum yield of loaded drug per sample area
was 140% higher in mPSi-CD than in nPSi-CD. With regards to drug release as a
function of sample mass, the increase was 19% higher in mPSi-CD than in nPSi-CD.
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These results matched with those obtained by TBO titrations. Plots of molecule load per
sample area indicate a significant advantage for mPSi-CD, but no significant differences
are observed when plots refer to normalization to sample mass.
CFX release profiles expressed in percent of maximum drug release are shown in
Fig. 20. In the CFX profiles in distilled water (Fig. 20-a) there is a clear contrasting
behavior between the fast release of unfunctionalized samples with respect to the
controlled release of functionalized samples. Nevertheless, in the case of CFX release
profiles in PBS (Fig. 20-b) the release in terms of percent of maximum drug release is
similar between unfunctionalized and functionalized samples. Comparing the profiles of
functionalized samples in both media one can observe that CFX release was 45-fold faster
in PBS medium (4 h) than in distilled water (180 h). This can be induced by three main
effects [33]: a) The competitor role of ions in PBS towards drug-CD inclusion complex.
This means that the ions displace the drug from the CD ring. b) The possible ionic
interactions between the protonated amino functions of CFX and the carboxylate groups
of polyCD are screened by the exceeding counterions brought by PBS. c) At neutral pH
the carboxylic groups of CD’s turn into carboxylate groups ionically repelling the CFX
carboxylate group from the polymer network. A combination of these three aspects takes
probably account for the accelerated release of CFX in PBS compared to pure water.
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Figure 18. CFX release profiles in distilled water normalized to sample area (a) and to sample mass (b).
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Figure 19. CFX release profiles in PBS normalized to sample area (a) and to sample mass (b).
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Figure 20. CFX release profiles as percent of maximum drug release in distilled water (a) and in PBS (b).
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PDN release profiles in distilled water and in PBS are shown in Fig. 21 and Fig.
22, respectively. In the case of nPSi-CD samples, they retained significantly more drug
than unfunctionalized ones; but in the case of mPSi-CD, they loaded similar amount drug
as unfunctionalized samples. Nevertheless, the release of mPSi-CD samples is more
controlled than in COx ones. The drug yield per sample area was 220% higher in mPSi-
CD than in nPSi-CD, and per sample mass was 40% higher in mPSi-CD than in nPSi-CD.
This tendency is also similar to what was observed for CFX and during TBO titration.
The functionalization degree normalized to sample area magnifies delivery rates in favor
of mPSi-CD, although data normalized to sample mass do not show such significant
differences.
Release time of PDN was also affected by the medium of release. The PDN
release of CD functionalized samples was around 32 fold faster in PBS medium (2.5 h)
than in distilled water (80 h) (Fig. 23).
From all these release profiles, it is possible to indicate that CFX is more
compatible with both hybrids (nPSi-CD and mPSi-CD) than PDN. CFX load was 10-fold
that of PDN. On the other hand, the release time was also longer for CFX than for PDN in
both hybrids: 2.25 times longer in distilled water and 1.6 times longer in PBS.
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Figure 21. PDN release profiles in distilled water normalized to sample area (a) and to sample mass (b).
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Figure 22. PDN release profiles in PBS normalized to sample area (a) and to sample mass (b).
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Figure 23. PDN release profiles as percent of maximum drug release in distilled water (a) and in PBS (b).
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3.4 Conclusions
Results from FTIR, XPS and water contact angle indicated that nano and macro
PSi layers were satisfactorily synthesized, properly stabilized by chemical oxidation and
further functionalized by β-cyclodextrin in-situ polymerization using citric acid as
crosslinking agent. The microscopic characterization showed clear topographic changes
of surfaces after each step (AFM) and that the polymer is integrated in PSi pores and top
surface (SEM). The amalgamation between the porous matrix and the polymer was
favored by two main phenomena: the PSi hydrophilic compatibility with the external wall
of CD after chemical oxidation, and the anchoring effect of the porous matrix. On the
other hand, the deposition and in vitro proliferation of L132 cells on both reference
samples and both composites proved their biocompatibility, despite their different cell
growth behavior on each sample.
Drug release profiles showed that functionalized samples have a longer release
time than COx ones. Higher drug loads are achieved and provide a better-controlled
release. The profiles were reported in two ways, normalized to area and normalized to
sample mass. The results significantly favor mPSi-CD over nPSi-CD when normalized to
area, but when results are normalized to mass they are similar due to nPSi being lighter
than mPSi.
The studies also indicated that CFX is more compatible with both composites
(nPSi-CD and mPSi-CD) than PDN: CFX load was 10 times higher than PDN load in
both composites. On the other hand, the release time for CFX was longer than for PDN in
both composites: one week in distilled water and 4 h in PBS for CFX; more than three
days in distilled water and 2.5 h in PBS for PDN. The faster release in PBS is due to the
ionic strength of salts in solution.
Finally, it is important to mention that the quantity of drug released by both
composites during the kinetic studies, confirms their potential for use in post-ophthalmic
surgery. It is reported that the CFX minimum inhibitory concentration required to inhibit
the growth of 90% of microorganisms (MIC90) goes from less than 0.25 to 2 μg/mL [34]
(less than 0.25 μg/ml for Bacillus sp. and Escherchia coli, while 0.5 μg/mL for
Corynebacterium sp. and Staphylococcus sp., and 2 μg/mL for Streptococcus sp.). As the
mean volume of an adult human eye is 6.5 mL [35], the required CFX dose into the eye
for a medical therapy is around 13 μg, a value not only reached but exceeded with just 1
mg of both PSi/CD hybrids synthesized.
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In the case of the use of PDN as an ocular anti-inflammatory, a minimum
concentration of 25 ng/mL is necessary to suppress inflammation and minimize side
effects of ophthalmic steroids, such as bulbar perforation, choroidal injection, central
retinal artery occlusion and others [36]. We can thus estimate that 0.16 μg of PDN are
required for a medical therapy. This value is also reached using 1 mg of any of the
PSi/CD hybrids, as derived from the kinetic studies.
In summary, by means of the characterization techniques and in vitro drug release
studies it was proved that layered composites of PSi and polyCD are functional devices
for drug delivery applications in post-ophthalmic surgery.
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Chapter 4:
PSi/Calcium Phosphate
Bioceramic Cell Scaffolds
4.1 Introduction
Scaffold-based osseous tissue engineering aims at repairing/regenerating bone
defects. Such a treatment involves seeding autologous cells throughout a biodegradable
scaffold to create a scaffold–cell hybrid [1]. Human mesenchymal stem cells (hMSCs)
derived from bone marrow are the most viable cells to contribute to the regeneration of
osseous tissues due to their potential to either, divide to produce more stem cells or to
differentiate into one or more tissues cells. That is to say, unspecialized hMSC cells
become specialized cells, for regeneration of tissues such as bone, cartilage, muscle,
ligament, tendon, adipose or stroma [2] (Fig. 1).
In this regard, porous silicon (PSi) provides an excellent platform for cell
scaffolds due to its biocompatibility [3], biodegradability [4] and bioresorbability [5]. To
promote its application as bone engineering scaffold supporting hMSCs, deposition of
calcium phosphate (CaP) ceramics in its hydroxyapatite (HAP, Ca10(PO4)6(OH)2) phase
has been suggested. This is because HAP is the main inorganic extracellular matrix
component of skeleton cells [6,7], supporting mobility [6], calcium reserve [8] and its role
in the regulation of metabolic energy [8-10]. HAP is a biocompatible and bioactive
material, capable of guiding bone formation and providing direct chemical bonds with
natural bone [8,11]. In Fig. 2, the phenomena that occur on the surface of HAP after
implantation is schematized: 1) In a fist stage after implantation, solubilization and ionic
exchange from the HAP surface start. 2) The solubilization of the HAP surface continues
a certain period depending on the electrolytic properties of the implantation medium. 3)
An equilibrium is reached between physiological ions and the modified surface of HAP.
4) Upon stabilization, the adsorption of proteins and organic material can proceed. 5-6)
The proteinaceous biofilm formed triggers Cell adhesion and proliferation. 7) Cells can
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initiate the production of new bone. 8) New bone is formed exhibiting natural bone
metabolism. For this reason synthetic HAP and other CaP phases have been used as bone
substitute materials in orthopaedics and dentistry applications [12-15].
Figure 1. Scheme of hMSCs differentiation (from Seong et. al. [7]).
Figure 2. Schematic diagram of the HAP surface after implantation. 1) Solubilization and ionic exchange
of the HAP surface. 2) Continuation of the HAP solubilization. 3) Equilibrium between physiological
solutions and HAP surface. 4) Adsorption of proteins. 5-6) Cell adhesion and proliferation. 7) New bone
production. 8) New bone formed (from Bertazzo et. al. [8]).
In that sense, this work focuses on the synthesis of PSi/CaP bioceramic cell
scaffolds by means of two different techniques for CaP deposition on PSi: Cyclic Spin
Coating (CSC) and Cyclic Electrochemical Activation (CEA) [16]. Since CaPs are ionic
compounds, both methods consist on alternate calcium (Ca) and phosphate (P) deposition
steps on nanostructered PSi. In this way, the individual variables of each step such as pH,
current density and reaction time, can be controlled and studied independently.
Herein, PSi/CaP composites synthesized through both processes are structurally,
morphologically and chemically studied in order to compare their ability to crystallize in
the HAP phase. Additionally, in the case of CEA deposition, we aim at monitoring the
CaP growth on PSi by the resistance increase of the electrodeposition process, in order to
open an understanding of the CaP growth mechanism.
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Moreover, HAP and other CaP phases present well defined Ca/P atomic ratios,
which are related to their degree of bioresorbability: a higher Ca/P ratio leads to a lower
bioresorbability rate [17-20]. This parameter is also linked to stability and bioactivity of
CaPs. Therefore, the growth of PSi/CaP composites with tailored bioresorbable properties
requires a precise control of the Ca/P ratio. Considering the stratified distribution of the
CaP phases deposited, we aim at a determination of the Ca/P atomic ratio by RBS [21].
Furthermore, the PSi-CaP interface was chemically studied by HAXPES (Section
2.2.2 –xi of Chapter 2). In addition to the use of hMSCs in the regeneration of osseous
tissues, they are also used to study the biocompatibility and bioactivity of materials
designed to orthopaedic and dental applications [22]. Therefore, the biocompatibility of
PSi/CaP bioceramics was tested by hMSCs culture.
4.2 Materials and Methods
4.2.1 Synthesis of PSi/calcium phosphate bioceramic scaffolds
In the previous chapter, two kinds of PSi were used: nPSi and mPSi, with an
average pore diameter of 30 nm and 1 μm, respectively. But in this chapter, nPSi was the
only substrate used for the synthesis of bioceramic cell scaffolds. Then, the label prefix ‘n’
was removed in this chapter leaving just PSi. PSi was synthesized using a current density
of 60 mA/cm2 for 90 s, rinsed in EtOH and dried with a nitrogen flow. Subsequent CaP
depositions on PSi were carried out by CSC and CEA (Section 2.2.3 –iii and –v in
Chapter 2, respectively). In CSC deposition, CaP was synthesized at different ratios of
Ca/P solution volumes (VCa/VP = 1, 1.67, 2) and under different pH of P solution (pH =
7.2, 9.7, 12.3), keeping constant the pH of Ca solution at 5.5. The standard condition was
set at VCa/VP = 1 and at pH = 7.2 of P solution.
In the case of CEA deposition, CaP was synthesized at different ratios of Ca/P
current densities (ICa/IP = 1, 1.67, 2) and Ca/P reaction times (tCa/tP = 1, 1.67, 2). The
standard condition was carried out at ICa/IP = 1 and tCa/tP = 1. All reactions were carried
out with fresh Ca-P solutions at room temperature. A thermal post-treatment at 600 C
and 800 °C for an hour was applied in standard samples made by CSC and CEA,
respectively. Additional PSi/CaP samples prepared by CEA were made for the analysis of
the CaP growth using HAXPES. For the monitoring of the CaP growth: samples were
prepared by reducing the standard reaction time of each cycle from 30 s to 7.5 s and other
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series by increasing the reaction temperature from 20°C to 37°C and 54°C. In order to
detect simultaneously Ca 1s, P 1s, and Si 1s core level signals by means of HAXPES, the
tCa/tP series were prepared by reducing the standard number of cycles from 20 to 2, with a
posterior thermal treatment at 600 °C for one hour. As reference, two samples were used.
One of PSi synthesized at 60 mA/cm2 for 90 s for Si 1s core level and other of HAP for
Ca 1s and P 1s core levels. HAP was synthesized on another PSi substrate at CEA
standard conditions: ICa/IP = 1 and tCa/tP = 1, during 20 Ca/P cycles (30 s each). Both
sample references were submitted to a posterior thermal treatment at 600 °C for one hour.
4.2.2 Characterization techniques
The morphology of PSi substrate and PSi/CaP composites prepared by both
techniques was observed by FESEM/SEM and their chemical composition was analyzed
by EDX, FTIR-SR and GA-XRD. In the case of CEA, the resistance increase of the
global process during CaP electrodepostion was obtained recording the characteristic
potential-time curve measured at constant current. Additionally, the quantification of the
Ca/P atomic ratio of samples was performed by RBS analysis at oxygen resonant energies.
In order to determine the chemical structure of PSi-CaP interface composites made by
CEA were characterized by HAXPES. Finally, the biocompatibility of PSi/CaP
composites obtained by both techniques was tested by hMSCs in vitro culture.
4.3 Results and Discussion
4.3.1 PSi/calcium-phosphate bioceramics synthesized by cyclic spin coating (CSC)
i) Physicochemical characterization
The synthesis of bioceramic composites was performed using a nanostructured
PSi layer as a biocompatible structure to support the CaP deposits. PSi layers were 3.2
m thick with an average pore diameter of 30 nm (Fig. 3-a and Fig. 3-b, respectively).
In order to study the morphology of CaP coatings obtained by CSC, a series of
SEM images were acquired. Additionally, EDX analyses were carried out to identify the
Ca and P containing structures. Fig. 4-a1 shows a top view of a CaP coating obtained at
standard conditions, which consists of a series of solid flat-plates forming flower-like
clusters with sizes between 10-20 m. This morphology has been previously related to
the brushite (BRU, CaHPO4·2H2O) phase [23]. The corresponding EDX spectra of CaP
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deposit on PSi showed a strong signal of Ca and P with some traces of Na (Fig. 4-a2). On
the other hand, by means of a cross-sectional SEM image (Fig. 4-b1), a height of around
7 μm of CaP clusters is observable. The EDX spectra of the image in Fig. 1-b2 indicates
that Ca and P were barely detected into the PSi structure, which suggests that PSi/CaP
samples prepared by CSC are rather a bilayer structure than an integrated composite.
Higher and lower magnification top views of the CaP clusters are shown in Fig. 5-
a and Fig. 5-b, respectively. The low magnification image illustrates how the clusters are
distributed over the PSi surface, with typical separations of tens of microns. The high
magnification image shows that solid flat-plates of CaP clusters have sizes of 3-20 μm.
Figure 3. FESEM images of the PSi synthesized using a current density of 60 mA/cm2 for 90 s and used in
CSC: a) cross sectional and b) top view.
Figure 4. CaP deposit on PSi by CSC at standard conditions (VCa/VP = 1 and pH = 7.2 of P solution): top
view [SEM (a1) and EDX (a2)], and cross section view [SEM (b1) and EDX (b2)].
ba
a1
b1
a2
b2
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Figure 5. Zoom-out (a) and zoom-in (b) of SEM images from top view of CaP deposit on PSi by CSC at
standard conditions (VCa/VP = 1 and at pH = 7.2 of P solution).
The chemical composition of freshly synthesized PSi, and after CaP deposition
was evaluated by SR-FTIR spectroscopy (Fig. 6). In Fig. 6-a, full spectra of both samples
are shown. The PSi spectrum shows relatively strong interference fringes, which are
typical of PSi layers of similar thickness [24,25]. In the case of the PSi/CaP spectrum, the
fringes fade because of the infrared absorption and increased surface roughness
associated to the CaP surface clusters. Fig. 6-b shows a zoom-in of both spectra to allow a
better identification of functional groups of samples. Characteristic Si-H bonds of
nanostructured PSi recently synthesized are identified at 2116, 906, 661 and 624 cm-1
[24,26]. In the case of PSi/CaP sample, absorptions in the range of 1190-976 cm-1 are
identified, which are related to PO4 3 in CaP structures [27,28], as well as the signal at
633 cm-1 of PO4 4 [28]. Additionally, the absorption at 873 cm-1 corresponding to CO3 3
is identified [28]. This carbonate peak is probably originated from the reaction of
hydroxyl ions with carbon dioxide (CO2 + 2OH-  CO3-2 + H2O), which get integrated
into the HAP structure [27]. An additional shoulder at around 1600 cm−1 is attributed to
the bending mode of O-H group from water [23].
a b
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Figure 6. SR-FTIR spectra of PSi and PSi/CaP obtained by CSC at standard conditions (VCa/VP = 1 and at
pH = 7.2 of P solution): a) full range spectra and b) zoom-in of spectra.
X-Ray diffraction studies were performed in order to determine the crystalline
structure of the CaP deposits. Fig. 7 shows a GA-XRD diagram of a PSi substrate. A
strong intensity peak at 55.7° is detected, which corresponds to Si after partial
amorphization due to transformation into PSi [29]. Fig. 8-a shows a GA-XRD diagrams
of the samples obtained by the CSC technique at different ratios of Ca/P solution volume
(VCa/VP = 1, 1.67, 2). This series of experiments revealed an evident crystallization in
6000 5000 4000 3000 2000 1000
0.0
0.5
1.0
1.5
2.0
PSiRe
fle
cta
nc
e (
a.u
.)
Wavenumber (cm-1)
PSi/CaP
2400 2000 1600 1200 800 400
0.0
0.5
1.0
1.5
2.0
Si-Hx
PO4v3
CO3v2
PO4v4
H2O
Si-Hx
Si-H2
Si-Hx
Re
fle
cta
nc
e (
a.u
.)
Wavenumber (cm-1)
PSi/CaP
PSi
a)
b)
Chapter 4
108
BRU phase [30], which is consistent with the previously observed morphologies (SEM)
and identified chemical bonds (SR-FTIR). However, at the highest VCa/VP ratio a slight
trace of HAP appears. The chemical formation of this CaP coating is in agreement with
the route for the chemical synthesis of BRU. Firstly, the PO4-3 is oxidized to HPO4-2 since
the P solution has a neutral pH [31], and then reacts with Ca+2 based on the next equation
[32]: + + 2 → · 2 (Eq. 1)
Since the basic environment favors HAP formation [33], we proceeded with a
series of CaP syntheses by CSC using the standard ratio (VCa/VP = 1) at different pH of
the P solution (pH = 7.2, 9.7, 12.3) (Fig. 3). In GA-XRD diagrams of Fig. 8-b it is
possible to observe a gradual increase of the peak related to HAP for increasing pH,
always in addition to the BRU structure. The competing reaction for HAP formation is
shown in the next equation [32]:10 + 6 + 2 → ( ) ( ) (Eq. 2)
However, although there are peaks corresponding to HAP, they do not indicate the
formation of a fully dominant HAP, as derived from some with relevant missing peaks
(i.e. 2= 31.8, 32.2, 32.9, 34.1 [34]).
Figure 7. GA-XRD diagram of PSi substrate synthesized at 60 mA/cm2 for 90 s.
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Figure 8. GA-XRD diagrams of PSi/CaP samples obtained by the CSC technique: a) at different
ratios of Ca/P volume (VCa/VP = 1, 1.67, 2) at neutral pH, and b) at different pH of P solution (pH = 7.2, 9.7,
12.3) at VCa/VP = 1. B = Brushite, H = Hydroxyapatite.
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Basic solutions are usually used to dissolve PSi [35] although the degradation rate
of PSi remains slow. In the case of basic CSC solutions, from the kinetic point of view,
the degradation is supposed to be negligible with respect to the fast CaP deposition rate.
Furthermore, the CSC technique works mostly on the top surface of the PSi as was
demonstrated by EDX analysis, which only detected Ca and P traces into the PSi layer,
not affecting the structural configuration of PSi (SEM and EDX analysis of Fig. 4).
The thermal stability of standard PSi/CaP (VCa/VP = 1 and at a neutral pH) was
analyzed after a thermal treatment at 600 °C for one hour (XRD diagrams in Fig. 9). BRU
was not stable at high temperatures. It suffered the typical thermally induced
transformation of an orthophosphate into a pyrophosphate according to the following
reactions [36]: 2 · 2 → + 4 (Eq. 3)2 → + (Eq. 4)
Eq. 3 represents the dehydration of BRU turning it into monotite (MON, CaHPO4),
and Eq. 4 the transformation of MON into calcium pyrophosphate (PYR, Ca2P2O7),
which occurs above 500 °C.
Figure 9. GA-XRD diagram of standard PSi/CaP sample obtained by the CSC at standard conditions
(VCa/VP = 1 and pH = 7.2 of P solution): at room temperature, and after post-thermal treatment at 600ºC.
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ii) Biocompatibility characterization
In order to evaluate the biocompatibility of PSi/CaP samples, cells were seeded
onto their surfaces. Fluorescence microscopy was used to characterize the attachment and
morphology of hMSCs onto PSi and PSi/CaP composite prepared by CSC at standard
conditions (Fig. 10). This composite was selected as reference to test the biocompatibility
because it was the sample within a dominant BRU structure. As a control, cells were
seeded on the PSi surface, where they were allowed to grow and attach for 24 h. The cells
cultured on PSi showed a normal morphological appearance (Fig. 10-a1 and 10-a2) and
an active mitosis (see arrows, Fig. 10-a1 and 10-a2). This behavior is in contrast with the
semispherical form that L132 cells adopted on PSi after 24 h of culture (Section 3.3.4 of
Chapter 3). In any case, it is convenient to remind that those PSi samples had been
previously chemically oxidized and that a different cell line had been used. In fact, a
drastic change in surface chemistry [37], and the culture of an alternative cell line [38]
can justify variations in the expected cell adhesion response.
Returning to the biocompatibility study of bioceramics by hMSCs, in the case of
the cells cultured on the PSi/CaP sample (Fig. 10-b1 and 10-b2), they showed a striated
actin cytoskeleton with long filopodia acquiring a shape conditioned by the solid flat
BRU clusters. This elongated cytoskeleton could be interpreted in terms of a migratory
state of cells on clusters. This is probably due to a state of minimum energy in cells
adhesion and/or to an influence of the extracellular ionic concentration gradient.
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Figure 10. Fluorescence microscopy images of hMSCs cultured on PSi (a1 and a2) and on PSi/CaP
composite prepared by CSC at standard conditions (VCa/VP = 1 and pH = 7.2 of P solution) (b1-b2) showing
actin cytoskeleton stained by phalloidin-Alexa488 and cell nuclei stained by DAPI.
Characterization results showed that CSC is a viable technique to synthesize
PSi/CaP bioceramics. The CaP particles deposited on PSi consisted of a series of solid
flat-plates with sizes of 10-20 μm. The BRU phase of CaP was strongly favored and
mostly deposited on PSi surface, resulting in a composite of two well defined layers.
4.3.2 PSi/calcium-phosphate bioceramics synthesized by cyclic electrochemical
activation (CEA)
i) Physicochemical characterization
CEA was the second cyclic technique used to deposit CaP on PSi. The same
independent Ca and P stem-solutions used in CSC (neutral pH, room temperature) were
utilized. As in the case of CSC, the morphology of the synthesized CaP coating was
observed by SEM and the identification of Ca and P elements was performed by EDX
a1 a2
b1 b2
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analysis. In the top view image of Fig. 11-a1, a CaP coating formed by CEA is shown. It
consists of agglomerates of circa 20 μm size randomly and heterogeneously distributed on
PSi. Besides, a strong signal of Ca and P atoms in its respective EDX spectra is indicated
(Fig. 11-a2). In the cross-section image of Fig. 11-b1 CaP agglomerates formed by CEA
are shown. A height of approximately 10 μm with respect to the PSi surface is observable.
Unlike in PSi/CaP prepared by CSC, for the PSi/CaP synthesized by CEA, the Ca and P
were intensely detected by EDX, even into the PSi layer, thus indicating a better
integration of both compounds (Fig. 11-b2).
Figure 11. CaP deposit on PSi by CEA at standard conditions (ICa/IP = 1 and tCa/tP = 1): top view [SEM (a1)
and EDX (a2)], and cross section view [SEM (b1) and EDX (b2)].
Higher magnification images of CaP clusters are shown in Fig. 12. Fig. 12-a
shows that the CaP particles are spherical, around 300 nm in diameter and Fig. 12-b
illustrates how the CaP particles are well-agglomerated in clusters. Morphologically, the
CaP particles are similar to others synthesized previously [39], although this particular
shape was obtained in an aqueous precipitation method at pH = 9 following a sintering
step at 950 ºC.
a1
a2
a2
b2
a1
b1
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Figure 12. Zoom-in of CaP particles synthesized by CEA at standard conditions (ICa/IP = 1 and tCa/tP = 1):
a) on PSi surface, and b) into agglomerates.
A characteristic of CEA is that CaP deposition on PSi can be monitored by
recording the applied potential during the electrodeposition carried out at a constant
current density. With increasing reaction time, or number of cycles in our case, cluster
density and size increase as illustrated in the SEM images corresponding to the 5th and
20th cycles (Fig. 13-a1 and 13-a2, respectively). The required potential also increases
with the number of cycles, as experimental V vs t curves of Ca and P deposition at the 5th
and 20th cycle show (Fig. 13-b1 and 13-b2, respectively).
In order to provide a model for the CaP deposition we have evaluated the
electrical parameters in the cell. The electrochemical system can be approximated to a
model consisting of a resistance and a capacitor connected in series. For a resistor-
capacitor circuit under direct current, the potential is given by [31]:= + ∫ (Eq. 5)
where V is the applied potential; i, the current; R, the resistance; C, the capacitance and t
is time. The asymptotic saturation of V to a constant value (Fig. 13-b1 and 13-b2)
suggests that the 1/C term in (Eq. 5) is negligible, which can be attributed to the high
capacitance associated with the large internal surface of PSi [24,40-42].
a b
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Figure 13. SEM images of CaP deposited on PSi prepared under standard conditions (ICa/IP = 1 and tCa/tP =
1): a1) at 5th cycle, a2) at 20th cycle; and V vs t curves for the 5th and 20th cycles: b1) corresponding to Ca
solution (cathodic current), and b2) corresponding to P solution (anodic current).
The constant potential V for a fixed electrodeposition current (1 mA/cm2, cathodic
current for Ca solution and anodic current for P solution), allows the determination of an
effective resistance value for each electrodeposition step by applying Ohm's law. The plot
in Fig. 14 shows that this effective resistance increases linearly with the number of cycles,
suggesting that CaP growth in PSi is also linear with the number of cycles. However, it is
possible that the resistance increase has some contribution from oxide formation in the
PSi matrix. As a consequence the voltage reached during the process is 3.3 V in Ca
solution and 2 V in P solution [43]. Different resistance plots for different conditions of
CaP deposition were obtained.
The SEM image of Fig. 15-a shows a lower density of CaP particles obtained with
20 cycles and 7.5 s per immersion cycle in comparison with the standard conditions of 30
s per cycle (Fig. 13-a2). The lower CaP deposition density is supported by the lower slope
in its corresponding resistance curves of Ca and P deposition (Fig. 15-b). Fig. 16 shows
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the resistance increment in each cycle of CaP electrodeposition at standard conditions but
at higher reaction temperatures: 37°C and 54°C (Fig. 16-a and Fig. 16-b, respectively).
Figure 14. Resistance increment per cycle for the independent Ca and P solutions. CaP electrodeposition
carried out at standard conditions (ICa/IP = 1 and tCa/tP = 1) and room temperature.
Figure 15. CaP deposited on PSi at standard conditions (ICa/IP = 1 and tCa/tP = 1) but reducing the time per
cycle to 7.5 s: a) SEM image, and b) resistance increase.
0 5 10 15 20
0
1
2
3
4
Re
si
st
an
ce
 (k
)
Cycle (No.)
 Ca
 P
0 5 10 15 20
0
1
2
3
4
R
es
is
ta
nc
e 
(k
)
Cycle (No.)
 Ca
 Pa b
PSi/Calcium Phosphate Bioceramic Cell Scaffolds
117
Figure 16. SEM images of CaP on PSi deposited at standard conditions (ICa/IP = 1 and tCa/tP = 1) increasing
the reaction temperature to: a1) 37°C, a2) 54°C; and their respective resistance increment curves: b1) 37°C,
b2) 54°C.
The equations of curves fitting the experimental data of the resistance increase as
a function of CaP deposition conditions are reported in Table 1. These curves generated
equations with coefficient of determination values (r2) very close to 1. According to these
experimental and fitting curves, the CaP deposition increases with the reaction
temperature owing to enhanced ion supply by diffusional transport and decreased
electrolyte viscosity [44]. Therefore, the resistance of the system is also increased. In fact,
the CaP deposition at 54 °C (Fig. 16-b2) was such that PSi surface was saturated at the
14th cycle, boosting up the applied potential. Previous studies (Ban et al. [45]) have also
reported that, in the electrochemical synthesis of CaP in this temperature range, the
diffusion process is a rate-determining step, which is increased in proportion to
temperature.
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Table 1. equations of the curves fitting the resistance increment during CaP
electrodeposition in different conditions.
x = Number of cycle (-)
y = Resistance (k)
Moving on to the chemical study of the PSi/CaP composites, SR-FTIR analysis
was carried out on the PSi before and after standard CaP deposition by CEA (Fig. 17). In
Fig. 17-a, full spectra of PSi and PSi/CaP samples are shown. The PSi spectrum shows
the typical interference fringes when PSi is formed as a thin layer [24,25]. As in the case
of the spectrum of PSi/CaP obtained by CSC, the spectrum of PSi/CaP synthesized by
CEA also shows faded fringes due to infrared absorption by CaP clusters, but in this case
the fading is more pronounced. Fig. 17-b shows a zoom-in to both spectra. The PSi
spectrum shows the characteristic Si-H bonds when PSi is recently synthesized: 2116,
906, 661 and 624 cm-1 [24,26]. In the case of PSi/CaP spectrum, PO4 3 peaks were
identified at 1091, 1042, 962 cm-1, which are related to CaP phases [27,28], besides the
signal at 602 cm-1 corresponding to PO4 4 [28]. Moreover, an absorption around 1455
cm-1 corresponding to CO3 3 was also identified [28].
Diffraction studies were performed in order to extract information relative to the
crystalline structure of the CaP samples deposited by CEA (Fig. 18). Fig. 18-a
corresponds to a series of experiments at different current density ratios (ICa/IP = 1, 1.67,
2) and Fig. 18-b to different reaction time ratios (tCa/tP = 1, 1.67, 2). The parameters of
current density and reaction time were selected with relation to the ion mobilities [31]. In
this way, the ICa/IP and tCa/tP series in CEA are equivalent to Ca and P condition variations
generated by VCa/VP in CSC.
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Figure 17. FTIR-SR spectra of PSi and PSi/CaP obtained by CEA at standard conditions (ICa/IP = 1 and
tCa/tP = 1): a) full spectra and b) zoom-in of spectra.
According to GA-XRD diagrams in Fig. 18-a, in the experiment of ICa/IP = 1, main
2 values corresponding to HAP [33,34,46] are well identified with a trace of MON. On
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the other hand, for the cases of ICa/IP = 1.67 and 2, traces of MON and BRU are notorious
within a dominant HAP structure too. In the case of GA-XRD diagrams in Fig. 18-b, the
main phases identified in the difractograms are the same as those found in the CSC
experiments. The more important difference is the lower crystallinity of HAP for tCa/tP =
1.67 and 2. The diffractogram corresponding to sample prepared at tCa/tP = 1.67 indicates
a relatively strong presence of BRU in HAP and the corresponding to tCa/tP = 2 shows a
solid solution of MON-BRU traces in HAP. The relative increase of these phases creates
a competitive environment for crystal growth that could not only affect to the quantity of
HAP formed but also to the quality of the HAP crystals formed, as suggested by the
increase of the width at half maximum of the peaks attributed to HAP.
From the evidences provided by the GA-XRD study it is possible to propose an
electrochemical mechanism for the growth of CaP on/in PSi. The process of cyclic
activation of Ca and P deposition onto PSi, taking into account the respective polarity of
the independent Ca and P solutions, is explained as a series of reduction-oxidation
reactions. The presence of MON and BRU traces in HAP suggests a sequence of
electrochemical reactions. At pH = 7.2 the phosphate ion formed is the monohydrated
HPO4-2 [31] and since the reduction potential of Ca+2 ions to metallic Ca is not yet
reached (-2.8 V) [31] until the 10th cycle, during the first 10 cycles there is only a
chemical formation of MON and BRU given by [47,48]:+ → (Eq. 6)+ + 2 → · 2 (Eq. 7)
That means that, at the beginning, each respective current density in each solution
works only as a force that moves ions to PSi enhancing the chemical reaction on its
surface. However, after the 10th cycle, in Ca solution there is a reduction from Ca+2 ion to
metallic Ca as observed previously [31,49]:+ 2 → (Eq. 8)
Then, the metallic Ca is oxidized to MON and BRU in the P solution as already
suggested [47,48], together with reactions of Eq. 6 and 7:+ → + 2 (Eq. 9)
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+ + 2 → · 2 + 2 (Eq. 10)
OH- ions are dominantly produced from reduction of water, although OH- can also
plausibly derive from ethanol dissolution and dissolved oxygen [50]:2 + 2 → + 2 (Eq. 11)+ 2 + 4 → 4 (Eq. 12)
Thus, the MON, BRU and metallic Ca react with OH- ions resulting in the
formation of HAP [48,50-52]:10 + 12 → ( ) ( ) + 4 + 10 (Eq. 13)10 · 2 + 12 → ( ) ( ) + 4 + 20 (Eq. 14)10 + 6 + 2 → ( ) ( ) + 20 (Eq. 15)
Due to the pH of the P solution, the PO4-3 reacts with water to produce HPO4-2[53]
and the process restarts again in reactions of Eq. 6,7,9 and/or 10. The MON and BRU
traces found when ICa/IP and tCa/tP ratios are increased may be attributed to the generation
of an excess of and metallic Ca, and the neutral pH of P solution. The excess of
and metallic Ca are transformed into MON and BRU due to the neutral pH. But at
the same time due to this neutral pH, some MON and BRU formed cannot react to
produce HAP because there are not enough PO4-3 and OH- ions to react. In fact, it has
been reported that the growth kinetic coefficients of HAP are smaller than those of BRU
by 18 orders of magnitude at pH 6.5 [30]. It is patent that basic conditions are more
favorable for HAP formation [33,36,54]. That is why unlike in the CSC method, which
affects mainly the top surface of PSi, basic pH could be not used. In fact, the CEA
technique is not compatible with working at basic conditions because the technique
implies ion permeability in the PSi layer. These layers risk thus getting dissolved when
immersed into basic solutions. This phenomenon is amplified in view of the long time of
PSi immersion in the basic solution since the overall growth process is relatively slow.
Chapter 4
122
Figure 18. GA-XRD diagrams at different ratios of: a) CaP deposited with ICa/IP = 1, 1.67, 2 for a tCa/tP =1,
and b) CaP deposited with tCa/tP = 1, 1.67, 2 for a ICa/IP = 1. H = Hydroxyapatite, M = Monotite, B =
Brushite.
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The stability of the synthesized HAP at room temperature was confirmed by the
thermal post-treatment at 800 C made for an hour (Fig. 19). The GA-XRD diffractogram
of the annealed sample presents the same phases identified in the diffractogram obtained
at room temperature. However, the annealing activates the crystalline structure as derived
from the better definition of the diffractogram peaks. Besides, the 800C diffractogram
presents other two main differences, the monotite peak at 30.2 is considerably reduced
and the HAP peak at 32.2 shows an enhanced definition.
Figure 19. GA-XRD diagrams of CaP deposits obtained at room temperature and after a thermal post-
treatment at 800 C. Sample prepared at standard conditions (ICa/IP = 1 and tCa/tP = 1). H = Hydroxyapatite,
M = Monotite.
As the evaluation of the Ca/P atomic ratio in CaP has become a clue indicator of
the stability, bioresorbability and bioactivity of HAP films, analysis by RBS has been
made on PSi/CaP composites synthesized by CEA where HAP was previously identified
by XRD diagrams. Fig. 20-a shows a representative Rutherford backscattering spectrum
obtained from a sample prepared at standard conditions (ICa/IP = 1 and tCa/tP = 1) and its
respective simulation using the RBS simulation code SIMNRA [55].
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Figure 20. a) RBS spectrum of PSi/CaP composite prepared at standard conditions (ICa/IP = 1 and tCa/tP = 1)
by CEA and its respective simulation, and b) concentration profile of PSi/CaP composite prepared at
standard conditions by CEA.
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Since the P and Si signal partially overlap in the spectrum, the individual
contribution of each element (Si, O, Ca and P) to the overall spectrum simulated is also
plotted. The in depth concentration profile (Fig. 20-b) was determined from the spectrum
simulations. This profile indicates atomic concentrations (normalized to 1) of 0.19 for Ca
and 0.114 for P at the top CaP surface. Si atoms are also detected in this layer because the
spectrum includes both the top of CaP clusters and the exposed areas of the PSi surface
since the film is not uniform (see Fig. 11-a1 and 11-b1). It is possible to identify the
beginning of the PSi layer at a depth of aproximately 3x1018 at/cm2, because there is a
sudden increase of oxygen related to silicon oxide (SiO2) in PSi [56]. On the other hand,
Ca and P were also detected at concentrations of 0.025 each one at depths over 4x1018
at/cm2, confirming the penetration of both elements into PSi structure, as initially
suggested by EDX (see Fig. 11-b2). Applying the same data analysis (simulation to
obtain profile concentrations) for both series of experiments made by CEA (ICa/IP = 1,
1.67, 2 and tCa/tP = 1, 1.67, 2), the profiles of Ca/P atomic ratios could be calculated (Fig.
21), as well as their respective error, by means of Poisson statistics [55]. The ideal Ca/P
value related to HAP was only obtained for ICa/IP = 1 and tCa/tP = 1, while for the other
two ratios (1.67 and 2), the Ca/P value was lower. This reduced value of the Ca/P ratio
indicates the formation of other CaP phases in addition to HAP. Besides, although the
calculated errors in the quantification of the Ca/P atomic ratios by RBS are considerable,
they denote a clear tendency. The CaP crystals of MON and BRU detected in GA-XRD
analysis (Fig. 18) match very well because their respective Ca/P atomic ratio is 1 [57]
reducing the ideal value of 1.67 corresponding to HAP. Additionally, although the Ca/P
atomic ratio is reduced when ICa/IP and tCa/tP are increased, the total amount of CaP
synthesized is not decreased. That is to say, the total amount of CaP deposited by CEA
increased when ICa/IP and tCa/tP were increased, but due to the multiplicity of the CaP
phases and the activation of the ion species at the interface, the Ca/P atomic ratio was
reduced.
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Figure 21. Quantification of the Ca/P atomic ratio by RBS of PSi/CaP composites prepared by CEA at
different ICa/IP (1, 1.67 and 2) and tCa/tP (1, 1.67 and 2).
ii) PSi-CaP interface characterization by HAXPES
CSC and CEA techniques were used to synthesize the PSi/CaP biocomposites, but
CaP integrated into PSi matrix was only obtained by means of CEA, irrespective of the
time or current conditions, as indicated by Ca and P detection within PSi by EDX and
RBS. In the case of PSi/CaP composites obtained by CSC, they were more like a bilayer
material. Therefore, in order to study the chemical composition of the PSi-CaP interface,
HAXPES analysis was carried out using a modified tCa/tP series of CEA (see Section
4.2.1). Si 1s, P 1s and Ca 1s core levels spectra were measured using different photon
excitation energies: 8.5, 12 and 15.5 keV. Fig. 22 shows spectra of PSi and HAP
references. Their backgrounds were subtracted using the Shirley model and all spectra
were smoothed, deconvoluted and normalized to their areas [58]. The data were processed
using the OriginPro 8 and XPS PEAK 4.1 software.
Si 1s core level analysis of PSi sample reference is shown in spectra of Fig. 22-a.
Results display two contributions at 1838.9 and 1843.6 eV, which are attributed to Si0 and
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SiO2 species, respectively. Split between both peaks is 4.7 eV, which is close to previous
reported value for Si 1s: 4.4 eV [59].
P 1s core level spectra of HAP reference prepared by CEA are shown in Fig. 22-b.
The peak detected at 2149.0 eV is very close to that assigned to P-O or P=O compounds
(2148.5 eV) [60], which are related to CaPs [61]. The peak of P0 at 2145.5 eV [62] was
also well identified. Ca 1s spectra of HAP reference are shown in Fig. 22-c. The Ca0
contribution was detected at 4038.5 eV [62] and an additional peak was identified at 4042
eV, which can be assigned to HAP phase. The HAP coating in reference sample
synthesized by CEA was previously confirmed by GA-XRD. However, at this moment,
no previous work regarding at Ca 1s oxidation states has been reported and a more
detailed study should be performed to provide a certain attribution of energy of Ca
species in different chemical states.
The full-width at half-maximum (FWHM) of all spectra increased when the
photon energy was increased, in such a way that resolution was lower for photon energies
above 12 keV [58]. Table 2, derived from Fig. 22 shows the Si0/SiO2, P0/(P-O + P=O)
and Ca0/HAP intensity ratios as a function of photon energy. With the exception Ca0/HAP
at 12 keV, the rest of neutral states/oxidized states intensity ratios tend to increase when
photon energy is increased. This strongly suggests the presence of an in-depth
composition gradient, with oxidized states exposing to the surface. The application of a
detailed theoretical model to explain these results is a complex task in view of the
heterogeneity of the samples and is considered out of the scope of this thesis.
Table 2. Si0/SiO2, P0/(P-O + P=O) and Ca0/HAP intensity ratios of references as a
function of photon excitation energy.
Ratio Photon excitation energy (keV) Intensity ratio
Si0/SiO2 8.5
12.0
15.5
0.4645
0.7033
0.8369
P0/(P-O + P=O) 8.5
12.0
15.5
0.1630
0.2407
0.5902
Ca0/HAP 8.5
12.0
15.5
0.2075
0.8109
0.3138
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Figure 22. Si 1s core level spectra of PSi reference obtained at 60 mA/cm2 for 90 s (a). P 1s (b) and Ca 1s
(c) core level spectra of HAP reference prepared by CEA at standard conditions: ICa/IP = 1 and tCa/tP = 1,
during 20 Ca/P cycles (30 s each). Measurements were carried out at 8.5, 12 and 15.5 keV. Spectra were
smoothed and normalized to their areas and their backgrounds were subtracted using a Shirley model.
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The Si 1s, P 1s and Ca 1s core levels spectra of tCa/tP series are shown in Fig. 23,
Fig. 24 and Fig. 25, respectively. As in the case of spectra references, their backgrounds
were subtracted using a Shirley model. Spectra were also smoothed, normalized to their
areas and deconvoluted into their respective contributions.
Si 1s core level analysis is shown in spectra of Fig. 23. Fig. 23-a corresponds to
tCa/tP = 1, Fig. 23-b to tCa/tP = 1.67 and Fig. 23-c to tCa/tP = 2. Results display the
previously identified peaks at 1838.9 and 1843.6 eV, which are attributed to Si0 and SiO2
species, respectively. As in the case of PSi reference, Si0/SiO2 intensity ratio also tends to
increase when photon energy is increased for three tCa/tP cases (Table 3), which evidences
the presence of an in-depth composition gradient, with oxidized species occupying the
sample surface.
Table 3. Si0/SiO2 intensity ratio as a function of photon excitation energy.
Sample Photon excitation energy (keV) Si0/SiO2
tCa/tP = 1 8.5
12.0
15.5
0.2159
0.3339
0.4404
tCa/tP = 1.67 8.5
12.0
15.5
0.3011
0.4070
0.6895
tCa/tP = 2 8.5
12.0
15.5
0.3084
0.3619
0.3370
P 1s core level spectra are shown in Fig. 24-a for tCa/tP = 1, Fig. 24-b for tCa/tP =
1.67 and Fig. 24-c for tCa/tP = 2. As in the case of the HAP reference, in the three tCa/tP
cases, two main contributions related to P-O or P=O compounds (2149.0 eV) were
identified. For P0 peak (2145.5 eV), just some traces were detected in most cases, as
illustrated by the reported P-O + P=O values in Table 4. The intensity of the P 1s
spectrum obtained at 15.5 keV in tCa/tP = 1 (Fig. 24-a) is notably decreased denoting a
limited P integration. On the other hand, an unusual peak at 2152.0 eV in the spectra of
tCa/tP = 2 was observed (see P* in Fig. 24-c). This contribution could be assigned to PYR
phase. Remind that for tCa/tP = 2 additional phases to HAP, MON and BRU are induced.
Since this sample was submitted to post-thermal treatment, the PYR is most surely
present as suggested by the associated GA-XRD results.
Chapter 4
130
Table 4. P0/(P-O + P=O) intensity ratio as a function of photon excitation energy.
Sample Photon excitation (keV) P0/(P-O+P=O) P*/(P-O+P=O)
tCa/tP = 1 8.5
12.0
15.5
0.0956
0.2226
0.1003
-
-
-
tCa/tP = 1.67 8.5
12.0
15.5
0.0365
0.0319
0.1384
-
-
-
tCa/tP = 2 8.5
12.0
15.5
0.0768a
0.0898a
1.2391a
0.0776
0.1374
1.5876
aNew P* component was not considered.
Lastly, Ca 1s core level spectra of tCa/tP series are shown in Fig. 25-a for tCa/tP = 1,
Fig. 25-b for tCa/tP = 1.67 and Fig. 25-c for tCa/tP = 2. Peaks related to Ca0 (4038.5 eV)
and HAP (4042 eV) were detected in all tCa/tP cases. Additionally for tCa/tP = 2 (Fig. 25-c),
an extra contribution at 4045.5 keV was identified (Ca*). This peak could be assigned to
PYR phase, which would match with the extra contribution detected in P spectra of tCa/tP
= 2. Besides, the peak intensity of this species also increased in depth as their crystalline
phase related spectra in the P 1s analysis (Fig. 4-c). As in the case of the P spectra at 15.5
keV for tCa/tP = 1 (Fig. 24-a), the intensity of the Ca spectrum obtained by this photon
energy was the lowest (Fig. 25-a). This denotes that there was also a limited Ca
integration into PSi for tCa/tP = 1. Thus, spectra of tCa/tP = 1.67 (Fig. 25-b) and tCa/tP = 2
(Fig. 25-c) showed a higher integration of Ca species into PSi structure than tCa/tP = 1 (Fig.
25-a). On the other hand, for tCa/tP = 1 and tCa/tP = 1.67, the Ca0/HAP intensity ratio tends
to increase when photon energy is increased, in contrast with tCa/tP = 2 (Table 5).
Table 5. Ca0/HAP intensity ratio as a function of photon excitation energy.
Sample Photon excitation (keV) Ca0/HAP Ca*/HAP
tCa/tP = 1 8.5
12.0
15.5
0.0353
0.2145
0.1264
-
-
-
tCa/tP = 1.67 8.5
12.0
15.5
0.0304
0.0552
0.4291
-
-
-
tCa/tP = 2 8.5
12.0
15.5
5.9524a
2.2945a
0.7859a
2.6829
2.3582
2.8974
aNew Ca* component was not considered.
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Figure 23. Si 1s core level spectra of PSi/CaP samples prepared by CEA measured at 8.5, 12 and 15.5 keV:
a) tCa/tP = 1, b) tCa/tP = 1.67, and c) tCa/tP = 2. Spectra were smoothed and normalized to their areas and their
backgrounds were subtracted using a Shirley model.
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Figure 24. P 1s core level spectra of PSi/CaP samples prepared by CEA, which were measured at 8.5, 12
and 15.5 keV: a) tCa/tP = 1, b) tCa/tP = 1.67, and c) tCa/tP = 2. Spectra were smoothed and normalized to their
areas and their backgrounds were subtracted using a Shirley model.
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Figure 25. Ca 1s core level spectra of PSi/CaP samples prepared by CEA, which were measured at 8.5, 12
and 15.5 keV: a) tCa/tP = 1, b) tCa/tP = 1.67, and c) tCa/tP = 2. Spectra were smoothed and normalized to their
areas and their backgrounds were subtracted using a Shirley model.
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According to the previous Ca 1s and P 1s core levels spectra, a scheme of CaP
particles nucleated on PSi could be developed (Fig. 26). Electrodeposition in tCa/tP = 1
generated the lowest penetration of Ca, thus also P, because P reacts with Ca nucleated on
PSi. In the case of tCa/tP = 1.67 and tCa/tP = 2, they promoted an increasing incorporation
of Ca species, thus also P. Besides, the tendency observed in the samples prepared in bulk
of tCa/tP = 2 to form multiple CaP phases (MON and BRU in addition to HAP), was also
repeated in the PSi-CaP interface due to PYR identification. However, in order to
strengthen this analysis, a more detailed study on Ca 1s oxidation states species is
required.
The scheme of Fig. 26 summarizes the influence of tCa/tP on the formation of CaP
in the two studied regions: bulk CaP (Section 4.3.2) and PSi-CaP interface (current
Section).
Figure 26. Influence of tCa/tP on the formation of CaP in different regions: PSi-CaP interface and bulk CaP.
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iii) Biocompatibility characterization
As in the case of composites prepared by CSC, the biocompatibility of PSi/CaP
composite prepared by CEA at standard conditions (ICa/IP = 1 and tCa/tP = 1) was also
studied by means of hMSCs culture. This PSi/CaP sample was selected to test the
biocompatibility of bioceramics because it was the sample containing a dominant HAP
phase. Fluorescence microscopy was used to characterize the attachment and morphology
of the hMSCs onto PSi and PSi/CaP sample (Fig. 26). The cells cultured on the composite
processed by CEA, presented a round expanded actin cytoskeleton, which indicates that
their ability for attaching to the surface is not challenged (Fig. 26-b1 and Fig. 26-b2).
Besides, cells are in active mitosis as on the PSi control (see arrows, 26-a1 and Fig. 26-
a2), which was not observed in the case of CSC samples. These results indicate a short
time scale biocompatibility due to the ability of the PSi/CaP composite prepared by CEA
to support hMSC adhesion and proliferation along with maintaining the normal
morphological appearance of cells.
Figure 26. Fluorescence microscopy images of hMSCs cultured on PSi (a1 and a2) and PSi/CaP
composites prepared by CEA at standard conditions (ICa/IP = 1 and tCa/tP = 1) (b1 and b2) showing actin
cytoskeleton stained by phalloidin-Alexa488 and cell nuclei stained by DAPI.
a1 a2
b1 b2
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4.4 Conclusions
This work demonstrated that the proposed methods based on cyclic CaP
deposition are suitable for the construction of PSi/CaP composites for bone engineering
scaffolds. Both techniques CSC and CEA consisted on alternate Ca and P deposition steps
on PSi. The morphology of CaP deposited on PSi was observed by SEM and their
chemical composition was analyzed by EDX, FTIR-SR and DRX. Both composite
synthesis techniques were studied in terms of the mineral phase grown and the
optimization for mineralizing CaP in its HAP phase was addressed. On one side, this
study reveals that the CSC and CEA techniques are suitable for producing specific
morphologies and CaP phases using the same independent Ca and P stem-solutions at
neutral pH and at room temperature. Besides, depending on the used technique it is
possible to form a bilayer material (PSi/CaP prepared by CSC) or an integrated composite
(PSi/CaP prepared by CEA). The BRU phase is favoured with the CSC technique and the
HAP phase is better synthesized using the CEA technique. In the case of CEA, an
approximation to the mechanism of CaP electrodeposition was studied by a simple system
resistance calculation. Results have shown that CaP deposition on PSi increases linearly
with the cycles when carried at room temperature, but the increase is exponential when
temperature reaction is increased.
On the other hand, the synthesis of HAP in PSi/CaP composite by CEA was
additionaly validated by Ca/P atomic ratio quantification by means of RBS. These results
indicated that controlling the synthesis parameters of CEA, it is possible to generate CaP
on PSi with a Ca/P atomic ratio of 1.67, the ideal value related to HAP. By means of
HAXPES it was possible to study the CaP-PSi interface. This study was performed using
a modified series of standard tCa/tP with cycle time of 30 s and a total of 2 cycles, which
were contrasted with the references, one of PSi and another of HAP prepared by CEA at
standard conditions. At this moment, there are no previous works regarding the Ca 1s
oxidation states, thus, two peaks of binding energy for the oxidized species of Ca 1s were
proposed: HAP at 4042 eV and PYR at 4045.5 eV. According to this, tCa/tP = 1 generates
the lowest penetration of CaP particles. In the case of tCa/tP = 1.67 and tCa/tP = 2, both
promote the incorporation of CaP particles into the PSi. Besides, tCa/tP = 2 tends to form
multiple CaP phases: HAP, MON and BRU. Then, according to this analysis, it is
recommendable to synthesize CaP on PSi starting with cycles of higher tCa/tP or ICa/IP
because these conditions enhance CaP penetration on PSi. On a second stage, if an HAP
phase is desired, it is recommended to reduce the tCa/tP ratio at 1. However, in order to
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validate this model, further studies regarding oxidation states from Ca 1s spectra are
indispensable.
Finally, the biocompatibility was demonstrated by the ability of the PSi/CaP
composite prepared by CEA to support bone-derived progenitor cells adhesion and
suggesting proliferation. In this regards, although cells cultured onto PSi/CaP provided by
CSC showed adhesion onto the surface, there was no evidence of proliferation. Moreover,
the culture on PSi/CaP composite obtained by CSC modified the normal morphological
appearance of cells acquiring the shape of the solid flat-plates of BRU clusters. In
addition, as the biocompatibility of composites was demonstrated using hMSCs, it opens
further work to create scaffold–cell hybrids for in vivo applications.
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Chapter 5:
Conclusions and Perspectives
5.1 Conclusions
In this thesis new modifications to porous silicon (PSi) were presented, which
allowed obtaining new advanced biomaterial structures. Specifically, the development of
new synthesis processes, the physicochemical characterization and the biocompatibility
testing of new PSi-based biomaterials has been described aiming at applications in drug
delivery and cell scaffolds. For the former application, this thesis has focused on the
development of PSi/Cyclodextrin Hybrids, while PSi/Calcium Phosphate Bioceramics
were prepared as cell scaffolds for skeletal tissues. The following specific conclusions
can be derived from the results presented in this thesis:
5.1.1 PSi/cyclodextrin drug delivery hybrids
i) Two kinds of PSi (nanoporous and macroporous) were used as substrates to
synthesize PSi/CD drug delivery hybrids. Both PSi matrices were properly stabilized by a
simple chemical route using hydrogen peroxide. As a consequence of stabilization, PSi
exhibited a transition towards a hydrophilic character as illustrated by water contact angle
technique. Such transition could be explained by the presence of Si-OH (identified by
FTIR-ATR and XPS). That hydrophilization was an essential requirement to functionalize
correctly both PSi substrates by β-cyclodextrin in-situ polymerization using citric acid as
crosslinking agent.
ii) Good adherence was achieved between the porous matrix of both types of PSi
substrates and β-cyclodextrin-citric acid polymer (polyCD). Such bonding strength was
induced by two main phenomena: the PSi hydrophilic compatibility with the external wall
of β-cyclodextrin after chemical oxidation, and the anchoring effect of the porous matrix.
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iii) The biocompatibility of synthesized PSi/CD hybrids and their respective
substrates was evaluated by means of the deposition and in vitro proliferation of L132
cells. Although different cell adhesion behaviors were observed on each sample, they
showed a viable cytocompatibility after 24 h of culture.
iv) In order to test PSi/cyclodextrin hybrids as potential intraocular drug delivery
systems, they were loaded with two drugs used in post-ophthalmic surgery: ciprofloxacin
(CFX, an antibiotic) and prednisolone (PDN, an anti-inflammatory). The kinetic studies
were carried out by means of drug release profiles in two different media: distilled water
and phosphate buffer saline (PBS). Drug release profiles showed that PSi/CD hybrids
have a longer release time, higher drug load and better-controlled release than their
respective PSi substrates. These studies also indicated that CFX is more compatible with
both hybrids than PDN in both media. The PBS medium generated a faster release than
distilled water due to the higher ionic strength in the buffer.
v) The functional dose of the hybrids to work as drug release systems for CFX and
PDN required in ocular medical therapy was estimated from the experimental drug
release data for each drug, and the volume of an adult human eye. Additionally, the
minimum inhibitory concentration required to inhibit the growth of 90% of
microorganisms (MIC90) was considered for CFX and the minimum concentration of
necessary PDN to suppress inflammation was taken into account for PDN. Quantities as
low as 1 mg of the PSi/cyclodextrin hybrids were considered functional.
5.1.2 PSi/calcium phosphate bioceramic cell scaffolds
i) Two alternative techniques to synthesize PSi/CaP biocomposites were proposed:
Cyclic Spin Coating (CSC) and Cyclic Electrochemical Activation (CEA). Since CaPs are
ionic compounds, both methods consisted on alternate Ca and P deposition steps on
nanostructered PSi. In this way, the individual variables of each step such as pH, current
density and reaction time, could be controlled and studied independently.
ii) CSC and CEA produced specific morphologies and CaP phases using the same
independent Ca and P stem-solutions at neutral pH and at room temperature. The brushite
(BRU) phase was favored with the CSC technique and the hydroxyapatite (HAP) phase
was better synthesized using the CEA technique.
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iii) The mechanism of CaP electrodeposition on PSi by CEA was studied by a
simple system resistance calculation. Results show that CaP deposition on PSi increases
linearly with cycles when performed at room temperature, but increases exponentially
when temperature reaction is increased.
iv) The synthesis of HAP in CaP/PSi composite by CEA was validated by Ca/P
atomic ratio quantification by means of RBS. These results indicated that, by controlling
the synthesis parameters of CEA, it is possible to generate CaP on PSi with a Ca/P atomic
ratio of 1.67, the ideal value related to HAP.
v) HAXPES was used in order to study the chemical structure of PSi-CaP
interfaces obtained by CEA. As previous studies regarding Ca 1s oxidation states have
not been reported, two contributions of binding energy for the oxidized species were
proposed: HAP at 4042 eV and PYR at 4045.5 eV. According to this, plus the obtained
spectra for Si 1s and P 1s, CaP integration into PSi structure is favored when tCa/tP ratio is
increased. Additionally, as in the case of the bulk region (studied by GA-XRD and RBS),
the HAP phase can be promoted in the PSi-CaP interface by means of controlling the
tCa/tP ratio.
vi) The biocompatibility of PSi/CaP composites obtained by both CaP deposition
techniques was tested by hMSCs in vitro culture. In the case of the composite synthesized
by CSC, cells showed adhesion onto the surface but without evidence of proliferation.
Besides, this composite modified the normal morphological appearance of cells, which
acquired the shape of the solid flat-plates of BRU clusters. In the case of composite
prepared by CEA, cells showed good adhesion, preliminary signs of proliferation and a
normal morphology.
As a final and general conclusion, results show the suitability of PSi as a
biomaterial for drug delivery and cell scaffold applications.
5.2 Perspectives
Materials, composites and devices based on PSi for biomedical applications are
spanning to the commercial dimension. Different companies market PSi for
bioapplications: pSiMedica Ltd. (UK), Silicon Kinetics (USA), pSivida (USA), and
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others. In that sense, further research on the biocomposites synthesized in this thesis
should be performed to promote the transfer to real applied devices.
In the case of PSi/CD hybrids, new drug release profiles in vitreous humour
medium could be carried out. As pig eyes are very similar to human eyes, they are an
option to be used for in vivo kinetic studies for drug release. Vitreous humour consists on
a gelatinous mass, which is 98-99% water and salts, sugars and proteins. Thus, drug
release in vitreous humour could present profiles between those obtained in distilled
water and those in PBS (vitreous humour is more viscous than distilled water and PBS,
which would increase the release time but salts inside would facilitate the drug release).
In addition, experiments could be carried out with additional antibiotics and anti-
inflammatories. Finally, for a complete understanding of the reactions occurring at the
oxidized PSi-polyCD interface an accurate investigation of the surface bonds, for
example through Raman spectroscopy, would be required.
In the case of PSi/CaP biocomposites, an adsorption of proteins and organic
material on CaP could be carried out for the elaboration of the scaffold–cell hybrids for in
vivo applications. The hMSCs compatibility was already proved, but biochemical factors
might help stem cells to differentiate into particular cell types (for bone, cartilage, muscle,
ligaments, tendons, adipose and stroma). On the other hand, due to the flexibility of both
CaP cyclic deposition techniques (CSC and CEA), an alternative way is opened for ionic
compound synthesis on PSi substrates such as carbonates, which would allow forming
new biocomposites. In addition, for other fields of application, CSC and CEA could be
used to synthesize different layers or mixed compounds on PSi, for example Fe-Au-Fe.
This material is used for magneto-resistive random-access memory applications. Finally,
in order to strengthen the results of chemical study on PSi-CaP interface of composites
obtained by CEA, a more detailed study should be performed to provide a certain
attribution of Ca 1s binding energy of different CaP phases.

Abstract
Porous silicon (PSi) is an excellent biomaterial given its biocompatibility,
biodegradability and bioresorbability. Nevertheless, it is necessary to adapt its properties
depending on the specific application. In that sense, two new PSi-based biomaterials were
developed to work in the field of drug delivery and cell scaffolds.
PSi-biopolymer hybrids are attractive as drug delivery devices because they
improve control over drug release kinetics and stability. According to this, two kinds of
PSi, nano- and macro-, were modified by β-cyclodextrin–citric-acid in-situ
polymerization. Both hybrids were characterized by microscopy and physicochemical
techniques. Its biocompatibility was proved by means of L132 cells in vitro culture.
Finally, both hybrids were tested as drug delivery systems with ciprofloxacin-base
(antibiotic) and prednisolone (anti-inflammatory), in two mediums, distilled water and
PBS. Results showed that both kinds of PSi/cyclodextrin hybrids, are functional for drug
delivery applications.
For the use PSi as cell scaffold in bone tissue engineering, deposition of calcium
phosphate (CaP) in its hydroxyapatite (HAP) phase provides an added value. Within this
context, the synthesis of CaP/PSi composites by means of two different techniques was
developed: Cyclic Spin Coating (CSC) and Cyclic Electrochemical Activation (CEA).
CSC and CEA consisted on alternate Ca and P deposition steps on PSi. Each technique
produced specific morphologies and CaP phases using the same independent Ca and P
stem-solutions at neutral pH. The brushite (BRU) phase was favored with CSC and the
HAP phase was better synthesized using CEA. Analyses by RBS on CaP/PSi synthesized
by CEA supported that, by controlling the CEA parameters, an HAP coating can be
promoted. Besides, its PSi-CaP interface was studied by HAXPES. Biocompatibility was
evaluated by bone-derived progenitor cells. Depending on the composite used to culture
cells, a characteristic response of adhered cells was obtained. These results can be used
for the design and optimization of CaP/PSi composites with enhanced biocompatibility
for bone-tissue engineering.
